TSS:Rfhg 235666.1

Basic information about the TSS

---

TSS ID: rfhg_235666.1 Species: human Chr: chrX		Start: 47223759 End: 47223763 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000523034.1:-121 GeneID: 5127 HGNC/MGI_ID: HGNC:8749 UniProt_ID: H0YBX5 Nearer transcript ids and distances:

Gene_name: CDK16 Gene_symbol: CDK16 Gene_synonyms: FLJ16665 PCTAIRE PCTAIRE1 PCTGAIRE Gene_source: HGNC:8749

TATA-Box annotation

---

Distance to TSS:	743
Nearest PromoterID:	NM_001170460
Entrez ID:	5127
Nearest Unigene:	Hs.496068
Nearest Refseq:	NM_006201
Nearest Ensembl:	ENSG00000102225
Gene Name:	CDK16
Gene Alias:	PCTAIRE|PCTAIRE1|PCTGAIRE|PCTK1
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.800000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CDK16 p2@CDK16 p3@CDK16 p4@CDK16 p5@CDK16 p6@CDK16 p7@CDK16 p9@CDK16
Sample		p1@CDK16	p2@CDK16	p3@CDK16	p4@CDK16	p5@CDK16	p6@CDK16	p7@CDK16	p9@CDK16
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	140.45	5.06	3.12	1.56	18.90	0.78	0.39	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	142.43	4.45	2.23	1.62	16.19	0.40	1.42	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	140.05	7.14	3.09	0.96	17.75	0.77	0.19	0.39
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	122.25	5.41	1.87	0.83	17.46	1.04	0.42	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	134.75	6.52	2.25	0.90	18.67	0.90	1.35	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	127.91	4.26	1.74	0.58	20.74	1.55	0.39	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	139.01	2.18	2.40	1.53	7.63	0.65	1.53	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	120.87	1.70	1.70	0.97	8.72	0.24	0.24	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	136.99	1.07	1.07	1.50	8.98	0.21	0.21	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	156.50	1.16	1.16	2.32	3.48	0.00	0.58	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	147.55	1.21	0.40	1.21	3.64	0.40	0.40	1.21
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	148.80	1.22	0.81	2.03	2.44	0.00	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	63.67	0.32	0.48	0.97	0.00	0.00	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	43.90	0.60	0.30	0.60	0.00	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	54.45	0.66	0.66	0.66	0.22	0.00	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	48.03	1.76	0.25	0.50	0.00	0.00	0.50	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	49.58	0.66	0.66	0.22	0.00	0.00	0.44	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	53.57	0.42	0.42	0.84	0.00	0.00	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	35.72	0.53	0.00	0.00	0.00	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	42.88	0.60	0.75	1.05	0.00	0.15	0.15	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	49.18	1.34	1.07	0.94	0.00	0.00	0.53	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	42.12	0.52	0.52	0.35	0.00	0.00	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	45.50	0.65	0.52	0.39	0.00	0.13	0.26	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	50.72	0.49	0.24	0.97	0.00	0.00	0.00	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	46.70	0.77	0.52	0.26	0.00	0.00	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	49.69	1.58	1.27	0.63	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	45.61	0.55	0.00	0.55	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	58.23	0.47	0.94	0.24	0.00	0.00	0.71	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	41.19	0.48	0.65	0.81	0.00	0.00	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	46.87	0.72	0.72	0.36	0.00	0.00	1.27	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	46.06	0.84	1.05	0.42	0.00	0.00	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	45.91	0.39	0.39	0.20	0.00	0.00	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	43.47	0.63	0.42	0.00	0.00	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	32.33	0.33	1.15	0.82	0.00	0.16	0.49	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	54.23	0.19	0.93	0.93	0.00	0.00	0.19	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	54.61	0.00	0.19	0.19	0.19	0.00	0.38	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	49.05	0.20	0.20	0.20	0.00	0.00	0.20	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	44.13	1.01	0.20	0.40	0.00	0.00	0.20	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	45.11	1.08	0.00	0.54	0.27	0.00	0.00	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	41.53	0.00	0.24	0.48	0.00	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	47.76	0.24	0.71	1.18	0.00	0.00	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	36.16	1.32	0.15	0.59	0.00	0.00	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	47.87	0.63	0.21	0.42	0.00	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	59.09	0.52	0.52	0.35	0.00	0.00	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	48.99	0.00	0.40	0.20	0.00	0.00	0.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	54.21	1.16	0.47	0.23	0.00	0.00	0.00	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	48.70	0.24	0.00	0.24	0.00	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	50.67	0.60	0.00	0.60	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	55.53	0.48	1.44	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	47.52	0.81	0.61	0.61	0.00	0.00	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	38.94	0.20	0.41	1.02	0.00	0.00	0.82	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	51.59	0.67	0.44	0.89	0.00	0.00	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	46.49	0.71	0.71	0.35	0.00	0.00	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	48.71	0.33	0.66	0.33	0.00	0.00	0.33	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.10	1.68	0.84	0.00	0.00	0.00	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	19.75	0.46	0.00	0.46	0.00	0.00	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	41.16	0.32	0.97	0.32	0.00	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	52.03	0.32	1.28	0.64	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	26.40	1.26	1.26	0.31	0.00	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	57.81	0.71	0.71	0.71	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	52.15	0.56	1.12	0.00	0.00	0.00	0.56	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	12.74	0.80	0.00	2.39	0.00	0.00	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	23.10	1.36	1.36	1.36	0.00	0.34	0.00	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	50.36	0.65	0.32	0.65	0.32	0.00	0.65	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	43.31	0.00	0.71	0.35	0.00	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	56.06	0.49	0.98	0.00	0.00	0.00	1.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	43.64	1.98	0.50	0.99	0.00	0.00	0.50	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	47.38	0.47	0.94	0.94	0.00	0.00	0.94	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	36.10	0.66	0.33	0.00	0.00	0.00	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	72.08	1.24	0.31	0.31	0.00	0.00	0.31	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	73.07	0.61	0.92	0.00	0.00	0.00	0.31	0.61
Adipocyte - breast, donor1	11376-118A8	62.56	2.06	1.74	0.63	0.48	0.32	0.32	0.16
Adipocyte - breast, donor2	11327-117E4	74.60	1.60	0.80	0.80	0.16	0.32	0.48	0.00
Adipocyte - omental, donor1	11473-119C6	72.27	2.04	1.91	1.65	0.89	0.25	0.76	0.00
Adipocyte - omental, donor2	11474-119C7	65.78	0.75	0.75	1.49	0.00	0.75	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	58.28	1.00	1.00	1.67	0.00	0.00	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	40.19	1.28	1.28	1.91	0.00	0.00	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	40.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	57.36	0.00	0.45	0.00	0.00	0.00	0.90	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	71.42	0.87	1.22	0.87	0.00	0.52	0.00	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	68.84	1.37	1.56	0.98	0.59	0.20	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	38.09	1.80	0.51	1.03	0.00	0.00	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	46.83	0.28	1.12	1.12	0.28	0.00	1.12	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	68.77	0.59	0.59	2.35	0.00	0.00	0.59	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	100.46	2.90	2.73	3.06	0.24	0.40	0.24	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	52.29	1.94	0.97	1.61	0.00	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	65.58	0.53	1.07	0.00	0.53	1.07	1.60	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	80.68	3.34	1.11	0.56	0.56	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	89.83	3.74	0.83	3.74	0.83	0.42	0.42	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	62.04	1.51	2.51	1.51	1.00	0.25	0.25	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	82.79	2.29	1.64	1.31	0.33	0.33	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	77.34	2.74	2.44	2.44	0.61	0.00	0.00	0.30
Alveolar Epithelial Cells, donor1	11510-119G7	91.27	1.55	2.87	0.88	0.22	0.22	0.22	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	121.92	3.23	3.23	2.51	0.36	0.00	0.36	1.79
Alveolar Epithelial Cells, donor3	11671-122G6	55.11	4.79	0.00	0.00	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	72.32	3.24	4.50	2.34	0.18	0.00	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	73.63	11.71	1.67	3.35	0.00	0.00	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	87.32	5.55	2.26	1.44	0.62	0.62	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	59.62	1.72	1.14	1.14	0.34	0.00	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	41.63	0.49	0.49	0.98	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	31.45	0.00	0.45	0.45	0.00	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	42.98	0.43	0.87	0.00	0.00	0.00	0.43	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	25.68	0.00	0.00	0.00	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	32.28	1.20	0.60	0.60	0.30	0.00	0.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	27.82	2.53	3.79	2.53	0.00	0.00	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	34.98	0.00	0.00	0.00	0.00	0.00	0.00	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	34.44	0.65	0.32	0.97	0.00	0.00	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	33.50	0.49	1.46	0.49	0.00	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	35.63	1.78	2.38	1.19	0.59	0.00	0.59	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	32.77	2.64	0.00	3.39	0.38	0.38	0.38	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	36.28	1.45	1.45	2.18	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	42.63	1.25	0.00	3.76	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	40.53	1.48	2.31	0.82	0.00	0.33	0.00	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	24.57	0.00	1.36	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	31.67	0.60	0.45	0.75	0.00	0.00	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	26.79	0.54	1.07	1.61	0.54	0.00	0.00	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	41.38	1.89	0.38	1.32	0.19	0.19	0.19	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	36.62	1.07	1.34	1.34	0.00	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	38.04	0.00	0.00	0.00	0.00	0.98	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	31.02	1.00	1.00	0.33	0.17	0.00	0.00	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	26.42	1.20	0.00	0.00	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	46.02	0.00	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	39.11	1.89	1.37	0.86	0.00	0.00	0.34	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	29.36	4.19	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	34.95	0.97	0.97	1.46	0.49	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	43.26	1.52	0.00	0.00	0.00	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	25.44	1.21	0.00	2.42	0.00	1.21	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	33.06	1.71	0.57	0.57	0.57	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	36.13	1.71	1.50	0.86	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	35.10	1.55	0.77	0.00	0.26	0.52	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	39.88	0.47	0.00	1.41	0.47	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	40.19	1.93	0.96	0.96	0.00	0.32	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	31.39	0.71	0.71	0.71	0.00	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	38.61	0.58	1.17	0.58	0.00	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	40.04	0.00	0.60	1.81	0.30	0.00	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	42.77	1.19	0.00	1.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	33.56	1.53	1.02	3.56	0.00	0.51	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	38.97	1.53	0.76	1.78	0.25	0.00	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	34.31	0.64	0.64	0.64	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	44.45	1.29	0.43	0.86	0.00	0.00	0.00	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	34.50	0.21	0.85	1.06	0.21	0.00	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	29.87	1.45	1.16	0.87	0.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	34.01	0.00	0.00	0.94	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	31.19	0.51	0.51	0.68	0.00	0.17	0.34	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	39.38	0.00	2.32	0.00	0.00	0.00	0.00	4.63
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	35.91	0.00	0.00	0.00	2.11	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	38.81	0.00	1.07	0.86	0.00	0.00	0.21	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	42.12	1.20	0.60	0.60	0.00	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	36.45	3.64	2.92	0.73	0.00	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	40.00	0.69	0.92	0.46	0.00	0.00	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	30.60	0.00	0.00	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	33.56	0.51	0.51	1.02	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	35.30	1.03	0.62	0.41	0.41	0.21	0.21	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	33.05	0.61	1.22	0.31	0.00	0.31	0.31	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	49.24	1.91	2.87	0.48	0.48	0.00	0.00	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	46.12	1.11	0.67	0.67	0.00	0.44	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	24.41	0.00	1.53	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	33.79	0.00	1.11	0.55	0.55	0.00	0.00	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	44.49	1.59	0.00	0.26	0.26	0.26	0.00	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	31.62	1.82	1.09	0.73	0.36	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	113.85	2.46	4.42	3.44	0.25	0.00	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	122.55	1.20	1.54	1.54	0.34	0.17	0.17	0.51
Astrocyte - cerebellum, donor3	11661-122F5	83.06	3.15	1.68	1.26	0.21	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	80.17	0.35	1.05	0.70	0.00	0.00	0.70	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	85.25	1.94	2.59	2.10	0.16	0.32	0.49	0.65
Astrocyte - cerebral cortex, donor3	11392-118C6	80.84	0.89	0.75	0.75	0.00	0.00	0.00	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	52.87	1.26	3.67	2.18	0.00	0.00	0.23	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	43.85	1.50	2.63	3.38	0.00	0.00	0.00	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	41.65	1.71	2.96	2.62	0.11	0.00	0.00	0.11
Basophils, donor1	12241-129G9	44.98	3.14	3.14	0.78	1.05	1.31	0.00	0.00
Basophils, donor2	12242-129H1	36.44	4.69	2.89	2.16	1.44	2.16	0.00	0.00
Basophils, donor3	12243-129H2	39.54	4.41	2.50	1.62	1.47	1.62	0.15	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	72.87	0.43	0.43	0.86	0.22	0.00	0.43	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	131.67	0.46	0.46	0.46	0.00	0.00	0.00	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	93.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	66.53	1.26	1.26	2.51	0.00	0.00	0.00	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	109.38	1.46	1.25	1.04	0.00	0.42	0.83	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	108.01	0.46	1.15	1.61	0.23	0.00	1.15	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	61.18	1.62	1.26	0.18	0.00	0.18	0.36	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	47.61	0.72	0.31	0.93	0.00	0.00	0.31	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	43.79	1.16	0.70	0.47	0.23	0.23	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	25.90	1.28	0.64	0.32	0.64	1.28	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	41.14	5.07	3.94	1.69	3.38	2.82	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	64.96	5.20	3.90	3.16	2.41	4.64	0.37	1.11
CD14+ Monocytes, donor3	11381-118B4	70.91	6.15	3.29	2.20	1.98	4.61	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	26.89	0.28	0.00	0.00	0.00	0.00	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	29.57	0.00	0.76	1.14	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	37.48	0.33	0.33	0.33	0.00	0.00	0.33	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	28.04	1.16	0.72	0.87	0.29	0.14	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	21.42	0.91	1.21	0.60	0.30	0.30	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	26.30	0.71	0.95	0.47	0.24	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	25.78	1.00	0.84	0.84	0.33	0.17	0.33	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	18.49	0.83	0.28	0.83	1.10	0.55	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	20.83	0.74	1.49	0.25	0.25	0.25	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	19.19	0.59	0.20	0.59	0.20	0.59	0.20	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	16.91	0.53	0.71	0.71	0.36	0.71	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	19.59	0.65	0.22	1.09	0.44	0.22	0.00	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	48.93	4.68	3.98	1.17	2.11	0.70	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	45.41	5.28	4.22	2.11	1.58	1.06	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	37.72	1.11	2.22	1.11	0.00	0.00	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	22.46	1.04	0.59	0.59	0.45	0.30	0.00	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	15.96	0.60	0.80	0.00	0.20	0.60	0.20	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	17.70	0.62	0.83	0.42	1.04	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	40.49	2.97	3.43	1.37	2.75	0.23	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	27.37	2.71	2.49	1.13	1.81	0.45	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	36.23	3.49	2.62	1.31	1.31	0.87	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	26.36	0.27	0.81	0.27	0.27	0.27	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	22.68	0.35	0.35	0.70	0.52	0.35	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	21.46	0.00	0.00	0.42	0.42	0.00	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	30.31	1.65	1.84	1.84	0.73	0.00	0.37	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	25.36	0.00	0.70	0.70	0.35	0.00	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	29.83	0.88	0.88	0.44	0.88	0.44	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	23.71	0.87	0.87	0.52	0.35	0.52	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	20.07	1.49	0.74	0.74	1.12	0.37	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	21.55	1.08	1.72	0.22	0.86	0.65	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	37.67	0.41	1.23	0.00	0.41	0.82	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	19.47	2.09	0.46	1.62	1.85	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	18.33	0.93	0.46	1.16	0.70	0.23	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	21.36	3.27	2.18	0.44	0.65	1.53	0.22	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	28.41	3.00	2.31	0.69	1.15	1.39	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	21.01	2.17	1.73	0.87	0.43	0.87	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	30.52	5.45	2.49	1.25	0.78	1.87	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	26.20	3.49	1.92	0.70	0.87	1.40	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	23.19	2.90	1.34	1.34	0.67	0.89	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	31.39	3.57	3.06	0.51	0.77	2.81	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	30.52	4.17	2.20	1.10	0.88	1.54	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	27.58	1.89	0.21	0.42	0.00	1.05	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	24.39	0.00	2.03	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	26.44	0.68	1.36	0.68	0.68	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	30.03	0.00	0.00	3.11	1.04	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	16.52	1.07	2.67	1.07	0.53	0.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	23.05	0.54	1.07	1.07	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	28.08	0.00	1.40	2.11	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	26.67	0.00	0.78	3.14	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	31.64	1.32	1.32	2.64	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	64.11	4.93	1.64	0.82	1.64	1.64	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	66.74	4.35	4.35	1.45	2.18	2.18	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	48.97	4.04	2.52	1.51	2.02	3.53	0.50	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	59.40	0.81	0.00	0.40	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	49.54	0.40	0.40	0.00	0.00	0.00	0.80	0.00
CD34+ Progenitors, donor1	11545-120B6	24.10	2.01	1.00	0.00	1.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	38.20	1.12	1.69	2.25	3.37	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	30.06	0.38	0.75	1.13	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	35.40	0.45	0.68	1.58	0.23	0.68	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	71.05	7.86	5.36	3.57	4.28	6.07	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	85.12	7.35	4.90	0.00	3.06	11.02	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	63.44	9.15	4.57	1.83	11.28	11.89	0.30	0.91
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	20.16	1.28	1.28	0.26	0.00	0.00	0.51	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	25.60	1.12	0.90	0.45	0.22	0.22	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	26.45	0.86	1.44	0.00	0.00	0.00	0.86	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	41.72	4.74	2.37	2.37	3.79	2.84	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	33.71	2.11	2.81	0.70	2.11	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	26.37	0.00	3.30	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	19.94	0.72	0.72	0.29	0.00	0.29	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	24.23	0.85	0.34	1.19	0.51	0.17	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	21.12	0.97	1.13	0.32	0.16	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	37.66	2.69	0.45	0.90	3.59	3.59	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	34.94	1.75	1.75	0.70	1.05	2.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	34.32	1.32	0.88	1.76	1.76	1.76	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	22.77	0.42	0.84	0.42	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	25.35	1.04	0.42	1.04	0.42	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	28.40	0.33	0.33	0.33	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	36.17	3.54	0.82	1.09	0.54	1.90	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	30.01	1.07	3.22	0.00	0.00	1.07	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	32.28	0.00	3.59	0.00	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	30.04	1.11	1.11	1.30	0.00	0.00	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	22.74	0.43	0.65	1.52	0.00	0.22	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	25.01	0.42	0.21	0.84	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	34.38	3.03	5.06	0.51	1.52	1.52	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	33.79	3.03	1.73	1.30	0.43	3.47	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	37.48	2.18	1.31	0.44	1.31	2.61	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	30.19	0.00	0.99	1.98	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	29.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	34.90	1.40	0.00	2.79	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	25.20	0.00	0.83	1.38	0.28	0.28	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	18.90	0.49	0.74	0.98	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	29.26	0.00	3.08	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	37.60	0.36	0.72	0.72	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	33.24	1.38	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	59.91	9.82	3.27	1.31	3.93	4.58	0.00	0.98
CD8+ T Cells, donor2	11307-117C2	66.83	9.39	2.63	0.75	4.51	8.63	0.75	0.38
CD8+ T Cells, donor3	11383-118B6	64.38	7.32	3.53	1.26	3.28	7.07	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	23.17	1.38	0.69	0.23	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	18.93	2.16	0.96	0.48	0.48	0.00	0.48	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	16.69	0.82	1.92	0.27	0.27	0.00	0.27	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	21.92	0.90	0.90	0.00	1.50	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	23.28	0.72	0.48	0.24	0.00	0.24	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	23.19	2.27	1.14	0.68	0.23	0.23	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	20.21	4.56	2.17	0.22	0.65	0.00	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	22.11	1.84	0.26	0.26	0.26	0.00	0.26	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	22.51	2.81	1.17	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	27.17	3.02	1.51	0.30	0.00	0.30	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	21.50	2.61	1.45	0.87	0.29	0.29	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	22.38	1.87	0.27	0.80	0.27	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	26.27	5.25	2.19	0.00	6.57	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	35.52	6.83	1.37	0.00	5.01	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.14	5.97	1.49	0.00	3.73	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	23.05	2.16	1.08	0.36	0.72	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	20.43	2.59	0.58	0.58	0.58	0.58	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	25.69	1.89	0.71	0.24	0.00	0.47	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	25.99	3.49	0.63	0.32	0.32	0.00	0.32	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	20.61	3.08	1.85	0.31	0.31	0.00	0.31	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	20.20	3.53	1.28	0.00	0.32	0.32	0.00	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	25.24	1.91	1.15	0.00	1.53	0.38	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	26.80	3.15	0.79	1.58	0.39	0.00	0.00	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	21.94	2.27	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	53.80	4.82	3.21	0.80	12.04	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	47.56	4.20	0.70	0.70	9.09	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	51.09	1.00	3.01	0.00	9.02	0.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	25.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	44.47	2.47	0.49	0.49	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	76.08	1.58	2.00	1.68	0.11	0.21	0.32	0.11
Chondrocyte - de diff, donor1	11261-116G1	68.99	0.69	2.08	1.04	0.69	0.35	0.00	0.35
Chondrocyte - de diff, donor2	11338-117F6	54.73	1.42	1.78	2.49	0.00	0.00	0.71	0.36
Chondrocyte - de diff, donor3	11410-118E6	54.50	1.48	1.48	0.80	0.11	0.46	0.00	0.34
Chondrocyte - re diff, donor2	11339-117F7	48.34	0.00	0.90	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	61.06	0.40	1.62	1.21	0.00	0.00	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	77.00	2.87	1.38	3.10	0.00	0.11	0.34	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	58.36	2.14	1.71	1.28	0.00	0.21	0.21	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	72.04	2.74	2.48	1.59	0.09	0.27	0.18	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	76.29	5.50	3.67	1.74	5.23	1.38	0.18	0.18
Corneal Epithelial Cells, donor1	11526-119I5	108.25	1.76	1.54	0.66	0.00	0.00	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	77.36	2.28	1.14	0.00	1.14	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	93.56	1.02	1.02	0.51	0.26	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	21.46	0.66	0.33	0.50	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	24.29	0.32	0.32	0.00	0.00	0.00	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	0.00	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	18.90	0.43	0.22	0.76	0.00	0.00	0.00	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	28.70	2.73	1.37	2.05	1.02	0.34	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	20.24	0.65	1.96	2.61	0.65	2.61	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	26.62	1.45	0.97	2.42	0.48	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	72.71	0.67	0.83	1.00	0.00	0.17	0.33	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	62.20	1.76	0.59	2.35	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	72.96	0.57	1.13	0.85	0.00	0.00	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	60.55	1.57	0.79	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	79.12	0.58	1.75	0.87	0.00	0.00	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	99.05	0.94	1.41	2.12	0.00	0.47	0.94	0.24
Endothelial Cells - Artery, donor3	11413-118E9	79.42	2.28	1.23	1.23	0.00	0.00	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	36.79	0.22	0.00	0.89	0.00	0.22	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	40.47	0.91	0.61	0.91	0.00	0.00	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	37.21	0.56	1.69	1.13	0.00	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	63.88	0.89	1.19	1.78	0.00	0.00	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	72.89	1.04	1.56	0.52	0.00	0.00	1.04	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	61.68	0.71	0.43	2.27	0.00	0.00	0.43	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	86.83	1.20	0.40	2.80	0.00	0.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	59.75	0.00	0.00	3.14	0.00	0.00	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	80.01	2.11	1.74	1.24	0.25	0.12	0.12	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	57.79	0.65	0.22	0.43	0.00	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	63.02	0.98	0.61	0.61	0.00	0.00	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	78.49	2.28	1.14	1.14	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	77.53	2.10	1.40	2.10	0.00	0.00	2.10	0.70
Endothelial Cells - Vein, donor3	11416-118F3	85.57	1.88	0.94	1.73	0.00	0.00	0.16	0.31
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	118.82	11.55	4.95	0.00	6.60	11.55	0.00	0.00
Eosinophils, donor3	12246-129H5	110.57	14.27	3.57	0.00	10.70	7.13	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	73.05	1.95	1.22	0.49	0.24	0.00	0.49	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	74.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	70.61	1.64	1.23	2.05	0.00	0.41	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	36.90	1.20	0.55	0.11	0.00	0.11	0.66	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	65.98	1.30	0.87	1.52	0.11	0.00	0.65	1.19
Fibroblast - Aortic Adventitial, donor1	11245-116E3	80.17	2.67	1.46	1.33	0.24	0.24	0.36	0.24
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	38.62	0.96	1.09	0.55	0.68	0.14	0.00	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	56.32	0.95	0.95	0.95	0.00	0.21	0.11	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	38.73	0.79	1.05	1.05	0.00	0.00	0.00	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	91.35	0.66	0.33	1.33	0.00	0.00	0.33	0.66
Fibroblast - Cardiac, donor1	11268-116G8	48.99	2.27	0.45	1.36	0.00	0.45	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	139.46	5.31	0.76	3.03	0.76	0.00	1.52	0.00
Fibroblast - Cardiac, donor3	11417-118F4	69.40	1.42	2.05	0.63	0.16	0.32	0.16	0.47
Fibroblast - Cardiac, donor4	11452-119A3	58.80	1.52	1.82	1.52	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	56.60	0.63	1.52	1.52	0.00	0.00	0.13	0.63
Fibroblast - Cardiac, donor6	11460-119B2	57.76	0.61	0.61	1.82	0.45	0.00	0.45	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	56.28	1.34	2.28	2.28	0.00	0.00	0.13	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	35.38	1.73	0.86	2.59	0.00	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	65.92	1.46	0.00	0.00	0.00	0.00	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	157.30	0.69	1.85	3.00	0.00	0.00	0.23	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	61.74	1.36	1.70	2.04	0.00	0.00	0.00	0.00
Fibroblast - Dermal, donor1	11269-116G9	36.16	0.23	0.23	0.70	0.23	0.00	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	88.20	1.42	0.94	0.00	0.47	0.00	1.42	0.47
Fibroblast - Dermal, donor3	11418-118F5	51.74	0.36	0.12	0.60	0.00	0.00	0.60	0.24
Fibroblast - Dermal, donor4	11450-119A1	79.70	0.34	0.79	0.45	0.00	0.00	0.23	0.79
Fibroblast - Dermal, donor5	11454-119A5	73.97	0.87	0.70	0.70	0.00	0.17	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	76.83	0.49	1.79	0.65	0.00	0.00	0.16	0.49
Fibroblast - Gingival, donor1	11237-116D4	48.10	1.04	1.25	0.62	0.21	0.21	0.00	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	63.67	2.36	1.57	1.57	0.00	0.00	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	82.10	0.79	0.79	0.53	0.00	0.00	0.26	0.92
Fibroblast - Gingival, donor3	11394-118C8	64.78	0.97	0.29	1.64	0.10	0.10	0.10	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	51.94	0.00	2.08	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	49.51	0.00	1.06	1.06	0.00	0.00	0.53	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	102.58	1.56	0.78	0.47	0.47	0.00	0.00	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	71.94	0.68	1.22	0.95	0.14	0.00	0.81	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	184.56	0.71	1.76	1.76	0.00	0.71	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	75.90	0.88	1.17	0.88	0.00	0.15	0.58	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	67.22	2.32	0.82	0.41	0.14	0.27	0.55	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	79.53	0.99	0.88	0.99	0.00	0.55	0.22	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	53.71	0.29	0.59	0.59	0.00	0.00	0.29	0.15
Fibroblast - Lung, donor1	11270-116H1	59.81	0.00	1.36	1.36	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	55.21	0.00	0.00	1.49	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	87.37	1.69	1.27	1.90	0.00	0.21	0.21	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	137.45	0.83	3.33	1.67	0.83	0.00	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	58.74	1.40	1.40	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	96.56	0.84	0.56	1.12	0.00	0.00	0.00	0.84
Fibroblast - Mammary, donor1	11540-120B1	152.24	2.44	1.22	0.81	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	99.86	3.99	0.00	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	75.07	1.55	0.19	0.58	0.00	0.00	0.00	0.39
Fibroblast - Periodontal Ligament, donor2	11319-117D5	106.78	1.06	1.67	1.06	0.15	0.00	0.46	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	69.77	1.22	0.31	1.22	0.00	0.00	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	59.15	0.38	1.14	1.53	0.00	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	58.59	0.81	0.54	1.35	0.00	0.00	0.81	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	48.71	0.46	0.58	0.58	0.00	0.12	0.00	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	56.48	1.88	0.77	0.55	0.11	0.11	0.11	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	119.27	1.83	1.42	2.24	0.00	0.00	0.00	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	84.86	0.67	1.34	1.34	0.67	0.00	0.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	54.96	0.79	0.79	0.79	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	64.30	1.59	0.79	1.19	0.20	0.79	0.00	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	47.07	1.07	0.89	0.89	0.00	0.00	0.53	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	49.27	1.18	0.99	0.99	0.00	0.00	0.20	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	38.51	0.60	0.30	1.81	0.00	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	55.49	0.65	1.19	1.30	0.00	0.11	0.65	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	36.44	0.25	1.27	1.77	0.00	0.25	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	53.98	1.80	1.64	1.15	0.00	0.16	0.16	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	42.91	1.20	1.20	1.40	0.40	0.20	0.00	0.20
Fibroblast - skin normal, donor2	11561-120D4	55.05	0.40	1.11	1.71	0.30	0.00	0.40	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	49.57	0.00	0.91	0.91	0.00	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	58.49	0.75	0.91	0.99	0.00	0.08	0.25	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	48.89	0.51	2.05	2.05	0.00	0.00	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	37.44	0.66	0.66	2.30	0.00	0.00	0.33	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	63.06	0.64	1.28	1.92	0.11	0.11	0.43	0.43
Fibroblast - skin walker warburg, donor1	11554-120C6	73.04	1.52	1.86	0.67	0.00	0.17	0.34	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	39.83	1.10	1.41	1.41	0.31	0.00	0.63	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	0.00	0.00	0.00	0.00	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	38.35	2.61	0.00	0.00	0.00	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	67.09	1.21	2.43	0.87	0.00	0.17	0.35	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	79.63	3.38	1.30	1.04	0.52	0.00	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	52.38	2.81	1.02	1.02	0.51	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	92.63	4.59	2.30	0.77	0.00	0.00	2.30	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	86.78	5.10	3.19	3.19	0.00	0.64	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	81.87	5.71	5.42	2.57	0.57	0.00	0.86	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	261.14	2.21	1.38	4.96	0.00	0.00	1.65	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	176.95	1.60	2.28	3.65	0.00	0.46	1.37	0.68
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	138.29	0.59	3.57	1.98	0.00	0.59	0.59	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	277.29	0.79	3.17	4.76	0.26	0.26	1.06	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	204.82	1.63	1.96	4.24	0.00	0.33	1.96	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	75.18	4.86	4.42	1.33	1.77	1.33	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	189.80	7.63	7.63	5.65	0.00	0.28	0.99	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	183.73	6.53	5.42	5.54	0.25	0.12	0.74	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	137.27	8.86	7.52	4.03	0.54	0.27	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	188.32	4.21	5.45	5.33	0.00	0.12	0.50	0.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	176.49	4.43	6.37	4.43	0.00	0.14	0.83	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	111.82	5.08	5.29	2.85	0.20	0.20	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	159.95	5.48	5.25	4.79	0.00	0.46	1.60	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	159.82	5.85	5.36	4.61	0.00	0.12	1.25	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	142.95	6.56	4.15	5.03	0.22	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	182.02	2.95	5.91	3.25	0.30	0.00	1.18	2.36
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	177.24	3.18	5.72	4.77	0.00	0.16	0.79	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	172.26	6.48	7.15	1.56	0.00	0.45	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	158.69	3.02	5.04	4.44	0.00	0.20	2.22	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	167.78	3.56	4.92	5.26	0.17	0.00	0.68	1.02
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	180.98	6.03	7.63	4.26	0.62	0.44	1.06	0.53
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	267.94	3.95	8.32	7.80	0.00	0.10	1.56	0.21
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	243.53	4.78	7.17	7.17	0.00	0.34	3.42	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	174.94	3.21	5.64	4.76	0.00	0.00	0.66	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	169.64	3.74	7.24	4.99	0.25	0.00	0.92	0.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	150.07	4.49	6.74	4.70	0.20	0.00	0.82	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	172.47	2.68	4.75	5.16	0.21	0.41	0.62	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	188.74	2.88	3.69	6.34	0.00	0.00	0.81	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	152.42	4.00	3.84	4.34	0.17	0.00	0.17	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	158.71	2.87	3.53	4.19	0.00	0.22	0.66	1.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	179.45	2.95	4.43	5.41	0.00	0.12	0.37	0.49
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	140.70	2.59	5.02	4.54	0.00	0.00	0.65	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	174.15	4.17	3.21	4.17	0.00	0.32	2.89	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	155.59	1.99	3.41	5.50	0.09	0.19	1.33	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	140.46	2.69	4.27	4.43	0.32	0.16	0.63	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	149.61	2.74	5.47	3.95	0.00	0.30	2.43	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	144.16	2.40	4.91	4.60	0.00	0.10	1.05	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	126.46	1.76	2.63	2.63	0.44	0.00	0.88	0.66
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	151.50	5.33	4.49	3.93	0.00	0.00	0.84	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	114.99	2.41	3.24	4.35	0.00	0.09	1.11	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	103.75	3.21	2.14	3.48	0.00	0.27	1.07	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	99.30	2.30	3.98	3.52	0.00	0.15	0.31	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	123.97	2.33	2.59	4.53	0.00	0.00	0.78	0.78
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	115.48	2.44	2.71	4.88	0.00	0.00	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	110.06	3.50	4.42	4.06	0.00	0.00	0.74	0.74
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	128.74	4.39	4.61	3.95	0.22	0.00	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	147.77	3.97	1.98	7.93	0.00	0.00	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	124.00	4.09	3.17	4.09	0.26	0.00	0.79	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	113.99	2.42	3.23	3.43	0.00	0.00	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	211.72	7.37	10.17	6.86	0.25	0.00	0.51	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	175.77	4.58	12.74	8.96	0.60	0.00	1.39	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	187.36	8.17	6.93	2.47	0.15	0.62	1.08	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	194.35	8.18	10.02	9.00	0.20	0.41	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	71.35	5.63	4.38	2.19	0.63	0.00	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	68.38	3.11	3.11	1.41	0.85	0.57	0.00	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	82.09	1.84	1.84	3.69	0.46	0.00	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	94.04	2.47	2.47	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	77.36	3.09	3.48	4.64	0.39	0.39	0.77	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	72.20	3.21	1.60	3.21	0.00	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	109.55	1.74	1.74	1.74	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	62.49	3.91	2.60	1.95	0.65	0.33	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	66.30	3.71	3.29	2.47	0.00	0.82	0.82	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	93.30	0.00	0.00	3.33	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	68.23	2.80	3.64	2.80	0.28	0.00	0.84	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	80.40	2.29	4.58	1.96	0.33	0.00	0.98	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	79.69	1.68	5.03	0.84	0.00	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	78.88	0.64	3.50	2.86	0.00	0.32	0.64	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	69.97	4.08	4.08	3.74	0.00	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	75.17	2.09	2.09	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	100.80	1.15	1.72	0.00	0.57	0.00	2.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	81.10	1.78	2.07	2.37	0.00	0.00	0.00	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	64.38	0.00	1.69	1.69	1.69	0.00	1.69	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	83.67	1.66	4.14	2.07	0.83	0.00	0.83	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	78.70	2.07	2.76	3.91	0.23	0.00	0.92	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	5.27	0.00	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	70.35	0.77	2.69	4.23	0.38	0.00	1.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	65.52	4.24	2.28	4.24	0.00	0.00	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	62.20	1.34	1.34	2.01	0.00	0.67	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	87.46	1.54	2.31	3.85	0.00	0.00	3.08	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	86.61	1.71	2.40	0.68	0.00	0.00	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	124.24	0.00	0.00	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	87.29	2.36	0.47	2.83	0.00	0.94	0.94	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	89.92	1.21	2.41	3.02	0.00	0.00	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	86.98	1.02	4.07	3.56	0.00	0.00	1.02	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	88.94	1.60	2.39	0.80	0.00	0.00	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	69.07	0.99	0.49	0.99	0.00	0.00	1.48	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	84.99	3.54	2.36	0.00	0.00	0.00	0.00	3.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	87.52	2.33	1.17	3.50	0.00	0.00	0.58	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	89.53	0.00	3.07	1.76	0.00	0.44	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	69.51	1.70	5.93	3.39	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	75.81	1.79	1.79	1.79	0.00	0.00	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	66.96	2.43	2.91	2.91	0.97	0.49	0.49	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	65.05	1.14	0.00	3.42	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	76.51	2.08	0.42	1.25	0.42	0.42	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	115.82	1.12	1.12	3.37	1.12	0.00	4.50	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	43.13	1.90	0.32	1.90	0.00	0.32	0.32	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	37.18	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	100.72	3.95	2.67	2.09	0.23	0.35	0.46	0.93
Hep-2 cells mock treated, biol_rep2	11899-125E9	116.47	3.88	4.39	4.22	0.34	0.34	0.68	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	99.19	1.14	2.50	1.59	0.68	0.00	0.23	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	102.31	4.15	3.06	2.51	0.98	0.44	0.55	1.09
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	110.04	2.58	2.15	3.01	0.43	0.21	0.86	0.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	96.45	3.23	3.01	2.15	0.22	0.22	0.00	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	96.77	2.86	3.24	2.24	0.00	0.37	0.12	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	93.32	2.92	3.77	2.74	0.17	0.00	0.86	0.69
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	90.34	4.49	2.24	1.60	0.32	0.00	0.64	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	68.27	0.00	0.56	3.36	0.00	0.00	1.12	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	107.77	0.43	0.43	2.16	0.00	0.00	0.00	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	47.59	0.00	0.00	2.64	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	88.89	3.53	2.12	2.12	1.06	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	71.92	1.45	2.18	0.73	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	58.40	1.75	1.40	0.70	0.70	0.17	0.17	0.70
Hepatocyte, donor1	11523-119I2	21.79	1.21	1.21	1.21	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	26.93	0.00	0.00	1.08	1.08	0.00	2.15	0.00
Hepatocyte, donor3	11684-122I1	19.63	0.00	0.61	0.61	0.00	0.00	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	50.26	1.96	1.31	0.65	0.00	1.31	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	87.92	6.82	3.67	2.97	0.70	0.87	0.17	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	61.88	2.61	2.88	1.10	0.27	0.00	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	120.99	0.00	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	113.48	0.00	6.68	20.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	135.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	80.29	0.00	0.00	1.38	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	90.10	2.50	0.00	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	94.83	0.00	2.56	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	105.13	0.00	0.00	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	128.32	0.00	3.25	4.87	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	70.03	0.00	6.67	0.00	1.67	0.00	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	65.35	0.00	0.00	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	109.85	1.32	0.00	2.65	0.00	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	70.95	1.11	4.43	3.33	0.00	0.00	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	146.67	0.00	5.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	89.44	0.63	0.00	1.26	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	80.42	1.55	1.55	4.64	0.00	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	92.38	0.65	0.65	0.00	0.00	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	122.35	0.00	0.00	1.61	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	167.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	128.75	0.81	0.81	2.44	0.00	0.00	0.00	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	96.98	1.26	0.00	2.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	0.00	0.00	0.00	0.00	0.00	0.00	14.37
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	98.85	0.80	1.61	0.80	0.00	0.00	0.80	2.41
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	87.71	2.77	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	120.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	76.47	0.47	0.94	0.47	0.00	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	57.14	0.91	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	118.37	1.08	1.08	2.15	0.00	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	73.69	0.00	2.54	1.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	107.77	0.64	0.64	5.10	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	78.37	3.65	1.82	1.82	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	126.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	106.40	0.00	1.43	2.14	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	102.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	69.45	0.62	0.62	1.23	0.00	0.00	0.62	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	86.05	1.76	1.76	3.51	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	100.58	0.00	0.00	0.00	0.00	0.00	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	84.14	0.00	1.39	0.70	0.00	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	106.23	0.00	2.21	0.00	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	100.50	0.00	0.00	9.73	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	121.20	0.87	0.87	0.00	0.00	0.00	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	125.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	111.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	136.55	0.00	1.07	4.27	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	67.89	2.77	1.39	2.77	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	54.14	0.00	0.00	2.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	107.69	0.00	0.00	1.84	0.00	0.00	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	111.94	0.00	0.00	3.03	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	136.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	132.17	1.06	0.00	0.00	0.00	0.00	1.06	1.06
Keratinocyte - epidermal, donor1	11272-116H3	74.58	5.71	3.18	0.57	0.90	0.57	0.24	0.24
Keratinocyte - epidermal, donor2	11349-117G8	117.13	0.59	2.34	3.51	0.00	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	68.81	0.47	0.66	1.04	0.09	0.00	0.09	0.57
Keratinocyte - oral, donor1	11251-116E9	119.65	2.72	1.59	0.68	0.23	0.34	0.23	0.45
Keratocytes, donor1	11527-119I6	161.26	0.00	0.34	1.38	0.00	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	93.74	0.00	0.00	2.34	0.00	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	56.32	0.40	0.59	0.59	0.00	0.00	0.00	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	76.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	67.96	3.24	1.08	0.00	0.00	0.00	1.08	1.08
Lens Epithelial Cells, donor2	11609-120I7	72.20	1.15	3.81	2.08	0.00	0.12	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	39.56	1.61	1.21	1.01	0.00	0.10	0.00	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	51.23	0.95	1.54	1.54	0.00	0.12	0.12	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	44.93	2.23	2.23	0.56	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	38.57	0.94	1.89	1.42	0.16	0.16	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	40.87	1.61	1.08	1.08	0.00	0.00	0.54	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	46.64	0.95	0.63	1.26	0.32	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	42.05	1.08	1.83	1.08	0.00	0.11	0.22	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	35.29	1.64	0.00	1.23	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	56.38	1.52	0.51	1.77	0.00	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	42.93	1.55	0.99	1.97	0.00	0.00	0.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	35.99	0.40	1.19	0.79	0.00	0.00	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	42.65	1.36	0.97	0.97	0.39	0.19	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	45.73	1.30	0.93	1.11	0.19	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	40.77	1.05	0.70	0.70	0.35	0.00	1.05	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	49.14	1.67	1.19	0.95	0.00	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	43.95	1.65	1.37	0.96	0.14	0.41	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	35.72	0.92	0.62	1.54	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	48.01	0.94	0.94	2.49	0.00	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	50.32	1.28	2.01	1.10	0.00	0.18	0.00	0.55
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	39.82	0.66	1.32	1.65	0.00	0.33	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	46.57	2.64	0.29	0.88	0.00	0.29	0.29	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	54.27	1.49	1.74	1.49	0.00	0.00	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	42.19	1.45	0.48	0.97	0.48	0.00	0.00	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	40.39	1.89	0.54	1.08	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	46.62	0.91	1.97	0.91	0.00	0.15	0.15	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	42.51	1.04	1.56	1.04	0.00	0.00	0.52	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	44.18	0.00	1.26	2.09	0.00	0.21	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	45.26	1.20	0.90	0.60	0.15	0.15	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	37.83	1.38	3.44	1.38	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	36.69	1.13	0.75	0.94	0.38	0.00	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	45.59	1.06	1.27	1.06	0.00	0.32	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	28.59	0.48	0.48	0.48	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	44.99	0.99	0.66	0.33	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	47.33	1.98	1.36	1.73	0.00	0.25	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	46.28	1.11	1.48	1.48	0.00	0.00	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	36.82	1.24	0.25	0.49	0.49	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	43.17	1.92	1.37	0.69	0.41	0.14	0.00	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	36.35	0.32	0.96	1.29	0.00	0.00	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	49.00	0.91	1.22	0.00	0.30	0.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	42.27	1.26	0.56	2.38	0.00	0.00	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	35.56	1.42	0.71	2.49	0.00	0.00	0.36	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	55.75	1.45	0.48	0.48	0.00	0.00	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	50.26	2.02	0.78	0.93	0.00	0.47	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	42.61	1.43	1.07	0.36	0.00	0.00	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	47.69	2.29	0.98	0.98	0.33	0.00	0.00	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	44.97	1.65	1.18	1.88	0.00	0.71	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	49.50	0.99	1.11	1.73	0.12	0.00	0.12	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	55.84	1.28	0.26	1.79	0.00	0.00	0.51	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	36.10	1.79	1.19	1.19	0.00	0.00	0.00	0.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	81.58	4.53	2.27	4.53	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	66.74	9.21	2.30	0.00	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	56.41	4.45	1.48	1.48	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	68.97	4.65	2.96	0.42	2.12	1.27	0.85	0.85
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	61.19	10.55	4.22	1.41	1.41	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	50.43	7.47	0.93	2.80	2.80	0.93	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	53.59	8.24	2.06	2.06	1.03	1.55	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	70.18	5.95	1.19	0.00	0.00	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	69.44	7.24	3.17	0.68	1.36	0.68	0.23	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	54.38	5.23	2.33	0.87	1.16	0.58	0.87	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	51.32	6.30	2.25	0.00	1.35	1.35	0.45	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	97.28	7.99	4.06	2.17	1.90	0.81	0.41	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	74.97	7.19	2.57	2.05	2.05	0.00	1.03	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	58.57	3.18	3.18	1.06	2.47	0.35	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	44.64	4.00	2.00	0.67	1.33	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	68.26	6.11	6.62	1.02	1.02	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	60.56	5.60	1.87	1.07	0.80	1.33	0.80	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	67.08	5.48	2.27	1.13	0.76	1.51	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	65.04	7.36	1.84	0.61	1.23	0.00	1.23	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	89.70	8.15	2.45	2.45	1.63	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	57.89	4.79	2.29	1.04	1.46	0.83	0.21	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	54.93	3.08	0.56	0.84	0.84	0.56	0.28	1.68
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	68.00	5.15	4.12	3.09	1.03	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	66.19	5.23	3.19	1.16	1.16	1.16	0.87	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	57.99	4.48	1.79	1.49	0.90	0.60	0.90	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	65.28	2.21	4.43	1.11	1.11	1.66	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	75.29	4.60	3.89	1.06	1.77	0.35	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	64.91	4.43	1.48	1.48	0.74	1.11	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	55.26	6.91	1.15	0.00	1.15	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	80.20	8.44	1.54	2.30	1.54	1.15	0.38	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	67.37	4.53	1.70	1.13	1.70	1.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	73.02	3.28	1.64	1.64	0.82	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	84.05	5.87	3.62	1.36	1.81	0.45	0.00	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	81.15	5.75	5.75	1.44	0.72	0.72	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	66.47	5.23	1.49	0.00	2.99	0.75	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	73.58	4.83	2.23	0.37	1.86	1.11	2.23	1.11
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	56.00	2.58	0.86	0.43	0.43	0.00	0.00	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	62.51	5.14	0.00	0.86	0.86	0.86	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	69.30	5.33	3.00	1.67	1.33	1.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	73.00	5.43	2.41	1.81	0.60	0.00	0.60	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	61.86	5.69	0.71	0.00	0.71	0.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	72.52	5.16	2.75	1.37	0.34	0.34	0.34	1.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	66.02	3.76	4.29	1.07	0.00	0.00	0.00	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	80.80	6.73	2.02	0.67	0.67	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	81.86	5.19	2.59	1.11	1.85	0.74	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	69.78	4.65	1.16	1.16	2.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	69.81	3.17	1.06	2.12	0.00	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	80.83	4.80	2.00	0.80	1.20	0.80	0.40	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	77.05	7.27	2.91	4.36	0.00	0.00	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	98.88	8.43	2.30	6.13	1.53	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	85.83	10.36	3.95	1.97	1.48	0.00	0.49	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	69.63	8.47	3.76	2.82	0.00	0.00	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	84.98	9.55	3.02	0.50	2.51	0.50	0.00	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	76.16	7.21	4.51	1.35	1.35	0.90	0.90	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	82.61	6.88	0.00	3.44	3.44	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	87.73	8.02	3.12	0.89	2.67	1.34	0.45	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	74.29	7.04	2.74	0.78	2.35	1.56	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	60.04	6.60	3.30	0.66	0.66	1.98	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	66.94	8.30	3.11	1.56	2.59	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	79.20	4.81	4.38	0.44	1.31	0.00	1.31	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	71.56	5.03	2.24	0.56	0.56	0.00	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	77.73	3.09	0.88	1.77	2.21	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	69.43	5.40	1.54	1.93	2.70	0.00	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	64.81	5.57	2.53	0.00	1.01	1.52	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	78.82	4.33	1.92	0.96	2.40	0.48	0.96	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	77.12	7.95	3.18	0.40	1.19	0.40	0.00	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	67.45	7.90	1.82	0.00	1.82	0.61	1.22	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	59.49	4.84	3.46	1.38	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	76.00	6.08	3.80	1.90	1.90	0.76	0.76	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	64.04	5.68	1.55	1.55	1.03	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	77.40	3.63	4.23	2.42	1.81	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	75.42	5.70	1.58	1.90	0.32	0.63	1.27	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	71.97	5.86	1.60	0.00	0.00	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	72.98	5.75	2.30	1.72	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	73.54	5.14	3.09	1.54	1.54	0.00	1.03	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	82.76	4.24	2.12	0.71	1.41	1.41	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	60.15	1.13	2.27	2.27	2.84	1.70	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	82.37	6.66	2.50	0.00	0.42	1.25	0.42	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	74.39	3.92	2.35	0.00	0.78	1.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	55.95	4.18	2.09	0.84	0.42	0.84	0.84	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	78.52	4.18	1.86	0.46	1.39	0.93	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	55.53	2.68	1.34	2.01	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	65.76	1.60	2.67	0.53	0.53	0.00	1.07	2.14
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	75.16	5.25	3.23	2.02	0.00	0.40	0.40	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	69.75	7.34	8.26	0.00	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	58.68	1.78	1.78	0.89	1.78	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	84.34	4.56	2.28	2.28	0.57	1.14	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	74.39	3.07	2.30	1.53	1.53	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	65.66	3.83	3.83	1.09	0.55	0.00	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	76.62	2.67	1.34	2.23	1.34	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	77.47	8.32	1.56	1.04	1.30	1.30	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	84.88	4.64	2.65	1.33	2.65	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	97.69	4.16	4.16	0.00	0.00	0.00	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	21.42	0.23	0.68	0.46	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	30.83	0.00	0.73	0.55	0.00	0.00	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	28.84	0.13	0.52	0.66	0.13	0.00	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	31.86	1.06	1.59	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	81.29	2.22	1.58	2.06	0.16	0.16	0.32	0.16
Mallassez-derived cells, donor3	11930-125I4	61.43	2.08	1.95	1.25	0.56	0.00	0.14	0.00
Mammary Epithelial Cell, donor1	11273-116H4	85.00	2.39	1.69	1.40	0.10	0.20	0.10	0.10
Mammary Epithelial Cell, donor2	11350-117G9	86.58	1.74	2.61	2.32	0.29	0.00	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	97.78	1.50	1.25	1.75	0.00	0.00	0.50	0.25
Mast cell - stimulated, donor1	11487-119E2	20.34	6.78	2.03	0.68	6.78	2.03	0.00	0.00
Mast cell, donor1	11563-120D6	28.44	0.32	0.76	0.54	0.00	0.00	0.11	0.00
Mast cell, donor2	11565-120D8	50.22	0.89	0.59	0.89	1.19	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	66.19	1.80	3.38	1.80	0.68	0.00	0.23	0.00
Mast cell, donor4	11567-120E1	42.37	1.24	1.06	1.77	0.89	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	26.61	0.67	0.22	0.89	0.22	0.00	0.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	37.36	1.75	1.17	0.00	0.58	1.17	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	34.76	0.11	0.34	0.69	0.00	0.00	0.34	0.11
Mast cell, expanded, donor8	11941-126A6	37.66	0.50	0.33	0.00	0.17	0.00	0.00	0.00
Melanocyte - dark, donor1	11502-119F8	59.60	0.80	1.59	0.90	0.00	0.10	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	50.53	2.08	1.04	0.69	0.35	0.00	0.35	0.69
Melanocyte - dark, donor3	11663-122F7	81.35	0.72	1.67	1.45	0.07	0.14	0.00	0.07
Melanocyte - light, donor1	11274-116H5	79.22	0.71	1.65	0.71	0.24	0.00	0.71	0.24
Melanocyte - light, donor2	11351-117H1	87.36	0.68	0.68	0.68	0.00	0.00	1.36	0.00
Melanocyte - light, donor3	11423-118G1	65.04	0.87	0.00	0.00	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	57.69	0.62	0.52	0.94	0.10	0.00	0.21	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	61.86	2.15	1.34	2.15	0.00	0.27	0.27	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	68.04	0.27	1.07	2.41	0.00	0.00	0.54	0.27
Meningeal Cells, donor1	11493-119E8	99.87	0.74	1.98	2.23	0.12	0.00	0.12	0.25
Meningeal Cells, donor2	11573-120E7	64.26	1.76	1.32	2.64	0.00	0.00	0.00	0.44
Meningeal Cells, donor3	11654-122E7	86.96	2.28	1.22	1.79	0.08	0.16	0.08	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	73.00	0.29	0.57	0.57	0.29	0.00	0.00	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	28.88	1.71	1.41	0.91	0.00	0.30	0.00	0.00
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	151.13	0.00	0.00	1.31	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	130.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	68.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	40.66	0.64	0.85	0.64	0.00	0.00	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	49.76	1.01	2.01	1.01	0.50	0.00	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	97.13	1.54	1.10	1.32	0.22	0.00	0.00	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	106.67	0.73	2.19	1.46	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	85.93	2.46	2.25	0.82	0.61	0.20	0.20	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	47.65	0.28	0.69	1.25	0.00	0.00	0.00	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	99.25	1.86	2.23	1.12	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	86.31	1.84	1.32	0.92	0.00	0.13	0.00	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	62.02	2.37	1.48	1.48	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	112.11	4.67	2.34	2.34	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	79.41	1.28	1.28	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	80.46	1.06	0.00	1.42	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	69.74	0.94	0.94	0.63	0.31	0.00	0.31	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	64.59	2.18	2.90	1.45	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	51.97	2.39	1.06	1.06	0.27	0.00	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	49.05	1.50	1.00	1.00	0.50	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	61.86	1.59	1.16	0.87	0.58	0.51	0.07	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	0.00	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	29.80	0.49	0.74	0.49	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	37.40	0.29	0.59	0.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	19.22	0.31	0.00	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	27.80	0.21	0.41	0.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	9.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	33.28	0.50	0.50	0.00	0.00	0.00	0.75	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	30.26	1.40	0.00	0.00	0.00	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	27.23	0.20	0.41	0.00	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	33.26	0.79	1.58	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	23.89	0.00	0.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	32.29	0.76	0.76	0.38	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	15.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	22.50	0.85	1.27	0.85	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	20.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	21.76	0.89	0.30	0.60	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	22.83	1.00	1.00	0.50	0.00	0.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	33.75	0.95	1.19	0.24	0.71	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	21.01	0.00	0.00	0.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	32.23	1.38	0.69	2.07	0.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	32.60	0.84	1.47	0.21	0.42	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	26.09	0.61	1.63	0.61	0.20	0.20	0.20	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	26.17	1.50	1.07	0.86	0.43	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	24.67	0.44	0.67	0.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	30.44	0.88	0.66	1.31	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	28.39	0.00	0.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	14.91	1.66	1.66	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	31.26	2.17	1.36	0.27	0.54	0.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	28.23	0.00	1.18	0.59	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	22.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	28.35	0.96	0.00	1.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	32.02	0.40	1.20	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	0.00	0.00	1.37	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	39.05	3.00	1.50	0.50	0.00	1.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	20.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	36.79	3.07	1.31	0.00	1.31	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	22.07	0.00	0.00	0.00	1.10	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	20.49	1.92	0.00	0.00	1.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	43.39	2.73	3.22	1.24	2.48	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	19.49	0.70	0.70	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	37.57	4.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	45.47	2.39	3.42	0.34	5.47	0.34	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	25.38	0.88	0.00	0.44	0.00	0.44	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	26.28	1.78	0.36	1.07	0.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	46.85	4.77	2.24	1.12	6.73	0.56	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	32.00	0.42	0.42	0.83	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	25.06	1.17	1.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	53.70	3.92	0.90	0.90	2.41	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	36.31	0.00	0.00	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	40.64	0.00	0.00	0.00	3.69	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	37.56	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	31.64	0.97	0.55	0.28	0.69	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	37.06	1.30	1.30	1.30	0.78	0.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	31.74	0.43	1.29	0.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	22.23	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	29.09	1.87	0.53	1.33	1.33	0.00	0.53	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	31.73	0.30	0.30	0.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	25.71	0.42	0.14	0.28	0.14	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	35.35	1.59	1.27	0.32	2.23	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	37.37	0.66	0.44	0.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	22.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	27.56	1.42	0.28	0.85	0.28	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	35.89	0.74	0.25	0.00	1.23	0.00	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	22.81	0.65	0.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	22.93	0.59	0.29	0.29	0.29	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	36.33	0.29	1.44	0.86	0.58	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	27.61	0.00	0.82	0.82	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	28.88	0.30	0.89	0.89	0.00	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	1.78	0.00	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	25.96	0.99	0.00	0.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	26.30	1.05	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	15.81	0.20	0.40	0.40	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	23.28	0.00	0.00	0.93	0.00	0.00	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	16.90	0.75	0.00	1.13	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	23.44	0.53	0.53	0.27	0.00	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	15.95	0.11	0.23	0.34	0.00	0.00	0.11	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	21.37	0.00	0.00	0.74	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	20.89	0.00	0.37	0.00	0.00	0.37	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	20.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.24	0.53	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	0.00	0.00	3.86	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	33.33	1.01	0.00	1.01	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	20.66	0.42	0.42	0.00	0.00	0.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	8.17	0.00	0.00	2.72	0.00	1.36	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	3.81	0.00	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	7.29	0.00	1.62	0.81	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	10.57	0.00	0.00	1.51	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	0.00	5.71	0.00	28.55	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	35.89	3.26	3.26	0.00	0.00	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	125.49	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	51.06	1.94	2.15	1.51	0.00	0.22	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	51.74	1.05	1.57	2.61	0.52	0.52	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	48.73	0.67	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	40.48	0.00	0.42	0.42	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	30.42	1.14	0.19	1.33	0.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	65.43	0.00	0.00	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	34.68	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	23.89	1.84	0.00	1.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	43.11	0.00	0.42	0.84	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	30.45	1.39	1.16	0.46	0.00	0.00	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	38.91	1.08	0.81	1.08	0.00	0.00	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	54.66	0.63	0.21	0.84	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	44.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	39.21	0.99	0.00	0.50	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	20.84	1.35	0.54	0.54	0.00	0.00	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	29.47	0.68	0.91	0.45	0.00	0.00	0.00	0.91
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	30.86	0.16	0.00	0.65	0.00	0.00	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	35.54	0.73	0.36	0.91	0.00	0.00	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	44.56	1.06	1.59	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	33.02	0.60	1.20	0.00	0.00	0.00	1.20	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	21.99	1.64	0.66	0.33	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	29.76	0.81	0.98	0.49	0.16	0.00	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	43.39	0.88	0.35	0.35	0.35	0.00	0.18	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	36.57	0.00	0.70	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	33.10	0.00	0.92	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	36.63	0.32	0.00	0.96	0.32	0.32	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	18.62	1.38	1.03	1.72	0.00	0.00	0.00	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	2.53	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	38.99	0.67	0.22	0.22	0.00	0.00	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	42.34	0.85	0.42	0.42	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	23.26	0.24	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	46.36	0.00	0.86	1.29	0.00	0.00	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	43.32	0.33	0.33	0.33	0.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	35.62	0.45	0.45	0.45	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	37.30	0.00	0.79	1.59	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	35.29	0.00	0.00	0.93	0.93	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	29.51	0.38	0.76	0.38	0.00	0.00	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	38.78	0.65	0.00	0.33	0.00	0.00	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	38.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	43.87	0.45	0.45	0.90	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	44.98	0.00	0.88	1.76	0.00	0.00	0.88	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	43.21	1.33	0.66	0.66	0.00	0.00	1.33	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	50.10	0.00	0.00	0.00	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	38.28	0.77	1.53	0.38	0.00	0.00	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	29.34	0.91	0.30	0.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	44.87	0.44	1.33	0.88	0.00	0.00	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	46.08	0.00	1.36	0.00	0.00	0.00	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	47.56	0.00	0.00	1.22	0.00	0.00	1.22	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	36.82	0.94	0.31	0.94	0.00	0.00	0.00	0.94
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	30.27	0.30	0.00	0.00	0.00	0.00	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	49.84	0.00	0.79	0.00	0.00	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	29.47	2.27	0.00	3.40	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	10.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	47.70	2.11	0.62	0.62	0.37	0.25	0.25	0.12
Myoblast, donor2	11322-117D8	47.76	0.58	1.92	1.34	0.00	0.77	0.38	0.00
Myoblast, donor3	11398-118D3	66.42	2.02	1.18	1.35	0.00	0.17	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	32.11	0.29	0.15	0.88	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	58.12	9.23	3.38	1.85	3.69	4.61	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	67.25	8.75	4.82	1.21	2.71	6.94	0.30	0.60
Natural Killer Cells, donor3	11387-118C1	64.23	5.52	3.68	1.66	4.79	7.36	0.00	0.74
Neural stem cells, donor1	11275-116H6	106.34	1.45	2.18	2.18	0.36	0.00	1.81	0.00
Neural stem cells, donor2	11352-117H2	138.65	1.93	3.85	3.85	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	104.69	1.14	0.00	5.69	0.00	0.00	1.14	0.00
Neurons, donor2	11574-120E8	101.94	0.66	2.20	4.40	0.00	0.00	0.44	0.66
Neurons, donor3	11655-122E8	69.06	1.64	4.11	4.11	0.00	0.00	0.82	2.47
Neutrophils, donor1	11233-116C9	87.23	11.14	5.57	0.00	2.78	1.86	0.93	0.00
Neutrophils, donor2	11314-117C9	46.38	2.90	0.00	0.00	0.00	2.90	2.90	0.00
Neutrophils, donor3	11390-118C4	94.07	11.61	7.94	2.44	4.89	3.67	2.44	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	58.54	0.83	1.31	1.19	0.12	0.12	0.24	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	46.89	0.98	1.30	0.98	0.33	0.00	0.33	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	39.71	0.80	0.80	1.20	0.00	0.00	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	42.26	0.69	0.96	1.51	0.00	0.28	0.41	0.28
Olfactory epithelial cells, donor2	11934-125I8	62.53	2.03	1.01	1.30	0.29	0.43	0.29	2.17
Olfactory epithelial cells, donor3	11935-125I9	44.38	1.82	0.68	1.36	0.00	0.34	0.23	0.23
Olfactory epithelial cells, donor4	11936-126A1	53.76	1.46	1.17	0.97	0.10	0.10	0.00	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	96.89	6.02	1.20	0.60	0.60	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	67.64	0.85	1.06	0.85	0.43	0.00	5.74	0.00
Osteoblast - differentiated, donor2	11353-117H3	40.01	0.00	1.14	0.00	0.00	0.00	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	36.62	0.62	0.62	0.62	0.00	0.00	0.00	1.24
Osteoblast, donor1	11277-116H8	95.37	2.54	1.56	1.95	0.20	0.00	0.20	0.20
Osteoblast, donor2	11354-117H4	77.96	2.81	4.21	2.81	0.00	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	97.57	0.71	1.07	1.24	0.18	0.18	0.71	0.53
Pancreatic stromal cells, donor1	11249-116E7	49.70	1.77	0.84	1.26	0.00	0.00	0.17	0.51
Pericytes, donor1	11491-119E6	87.57	1.67	2.78	3.34	0.00	0.11	0.33	0.00
Pericytes, donor2	11571-120E5	72.44	0.68	0.91	2.26	0.00	0.00	0.23	0.68
Pericytes, donor3	11652-122E5	89.92	1.63	1.42	2.03	0.20	0.41	0.41	0.81
Perineurial Cells, donor1	11499-119F5	99.68	1.81	2.26	1.36	0.11	0.23	0.11	0.34
Perineurial Cells, donor2	11579-120F4	59.16	1.47	1.10	1.38	0.00	0.28	0.18	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	44.62	4.14	1.91	1.59	1.91	1.27	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	40.65	3.67	0.73	0.73	2.20	1.96	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	46.46	4.01	2.07	1.42	0.91	3.62	0.26	0.00
Placental Epithelial Cells, donor1	11278-116H9	67.21	1.43	2.15	0.24	0.00	0.00	0.24	0.48
Placental Epithelial Cells, donor2	11355-117H5	102.02	5.54	1.11	3.33	0.00	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	93.26	3.34	2.55	1.77	0.00	0.20	0.20	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	60.76	1.58	0.32	0.32	0.00	0.32	0.32	0.95
Preadipocyte - breast, donor1	11467-119B9	71.66	1.88	1.50	0.56	0.00	0.19	0.94	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	35.37	0.78	1.17	1.04	0.13	0.26	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	67.32	1.35	0.90	0.45	0.23	0.00	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	70.86	2.13	2.24	1.92	0.43	0.96	0.64	0.11
Preadipocyte - omental, donor2	11329-117E6	70.71	0.87	2.62	1.31	0.00	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	72.05	0.86	1.43	1.00	0.43	0.00	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	62.01	1.97	3.94	0.98	0.98	0.00	1.97	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	113.33	0.92	2.46	0.31	0.61	0.31	0.92	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	105.72	0.89	1.06	1.59	0.18	0.35	1.24	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	87.87	1.36	0.51	0.68	0.00	0.17	0.85	0.00
Preadipocyte - visceral, donor1	11280-116I2	82.90	1.21	1.12	1.58	0.37	0.28	0.19	0.00
Preadipocyte - visceral, donor2	11357-117H7	60.28	0.92	0.00	0.00	0.00	0.46	0.00	1.38
Preadipocyte - visceral, donor3	11429-118G7	60.40	0.31	0.73	0.94	0.00	0.10	0.21	0.94
Prostate Epithelial Cells (polarized), donor1	11253-116F2	84.78	4.22	2.72	1.51	0.60	0.91	0.60	0.30
Prostate Epithelial Cells, donor2	11331-117E8	51.05	2.71	2.57	0.81	0.68	0.95	0.41	0.54
Prostate Epithelial Cells, donor3	11404-118D9	77.47	0.43	0.73	0.86	0.06	0.06	0.12	0.49
Prostate Stromal Cells, donor1	11254-116F3	63.33	2.62	1.14	0.57	0.23	0.11	0.46	0.00
Prostate Stromal Cells, donor2	11332-117E9	59.35	1.61	0.54	1.08	0.36	0.00	0.18	0.54
Prostate Stromal Cells, donor3	11405-118E1	53.70	1.36	1.46	1.15	0.00	0.00	0.42	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	105.48	3.65	4.74	0.00	0.36	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	66.61	2.36	2.56	0.97	0.07	0.00	0.07	0.35
Renal Epithelial Cells, donor1	11517-119H5	146.08	3.04	2.54	2.03	0.00	0.00	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	85.36	2.85	0.71	2.85	0.00	0.00	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	77.81	2.43	2.65	1.16	0.00	0.00	0.11	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	61.96	0.00	0.00	0.00	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	80.59	0.94	1.35	0.94	0.00	0.00	0.40	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	58.39	1.33	0.89	0.22	0.00	0.44	0.00	1.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	97.82	0.67	0.67	0.67	0.00	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	130.51	3.74	4.84	1.54	0.22	0.22	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	115.37	4.39	2.51	2.51	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	110.69	4.44	4.99	1.94	0.28	0.28	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	134.48	2.15	2.95	2.68	0.00	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	95.72	2.11	2.95	3.80	0.00	0.84	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	114.55	2.89	2.51	2.51	0.77	0.00	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	106.05	4.15	1.81	2.07	0.78	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	72.20	2.27	3.13	3.13	0.28	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	109.09	1.03	1.03	3.09	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	54.95	1.51	2.26	1.00	0.25	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	38.75	0.94	1.20	1.20	0.00	0.13	0.40	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	131.33	0.00	1.79	3.57	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	96.87	0.55	5.50	3.85	0.00	0.00	6.05	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	100.35	0.00	2.32	1.16	0.00	0.00	1.74	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	119.62	2.08	5.72	2.99	0.13	0.00	0.13	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	148.86	2.88	4.27	4.47	0.20	0.20	0.60	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	153.48	3.79	7.14	5.47	0.22	0.00	0.33	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	175.03	2.85	7.07	7.69	0.12	0.00	0.00	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	162.11	2.45	4.78	3.03	0.23	0.12	1.05	1.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	156.94	3.70	5.32	2.31	0.00	0.46	0.46	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	127.33	1.92	6.85	6.30	0.14	0.14	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	148.55	2.12	5.29	3.33	0.00	0.30	0.76	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	152.31	1.97	4.84	3.58	0.18	0.00	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	138.72	2.01	6.74	5.02	0.14	0.14	0.14	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	155.61	3.65	4.51	3.86	0.21	0.21	0.32	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	144.71	2.66	5.97	4.87	0.00	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	112.60	1.53	4.01	5.93	0.19	0.00	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	139.00	2.52	4.19	4.47	0.00	0.00	0.37	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	151.27	4.89	6.58	3.76	0.19	0.00	0.56	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	115.32	1.59	5.31	4.91	0.13	0.00	0.53	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	162.85	2.53	5.74	4.48	0.00	0.00	0.39	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	166.13	3.44	5.35	2.86	0.19	0.00	0.00	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	125.91	1.50	3.95	3.74	0.00	0.00	0.11	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	138.47	2.24	7.85	3.36	0.28	0.00	1.12	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	143.55	3.93	5.81	3.08	0.00	0.00	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	121.43	1.28	4.01	3.65	0.00	0.36	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	169.72	3.19	5.52	4.91	0.25	0.25	1.47	1.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	163.74	4.16	6.04	4.43	0.00	0.13	0.54	0.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	139.16	3.07	8.49	7.08	0.24	0.00	0.24	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	157.74	2.98	6.15	5.16	0.20	0.60	0.60	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	151.06	2.57	4.21	4.44	0.00	0.23	0.47	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	142.25	1.24	5.39	4.15	0.21	0.00	0.62	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	125.43	3.54	5.97	2.65	0.00	0.22	0.22	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	139.95	3.76	4.18	4.18	0.00	0.00	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	142.53	2.96	6.46	6.06	0.13	0.00	0.54	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	133.85	2.55	2.38	4.26	0.00	0.17	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	142.48	4.05	4.05	3.28	0.00	0.00	0.77	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	140.82	2.41	4.99	5.67	0.00	0.00	1.20	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	136.35	2.47	3.15	2.88	0.41	0.00	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	140.86	1.48	3.94	2.46	0.00	0.16	0.82	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	115.89	1.53	4.60	3.92	0.00	0.00	1.19	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	174.15	4.73	5.47	3.40	0.44	0.30	0.44	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	140.47	3.20	4.80	3.20	0.00	0.00	0.53	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	120.29	0.83	2.90	3.87	0.00	0.00	1.11	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	156.67	1.90	4.52	4.76	0.00	0.00	0.48	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	181.19	1.81	4.23	3.02	0.00	0.00	0.20	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	147.38	0.94	7.53	5.37	0.00	0.09	0.85	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	182.72	1.40	3.14	3.14	0.00	0.00	1.40	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	113.33	0.91	3.02	1.51	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	155.06	1.35	5.26	5.02	0.00	0.00	1.47	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	202.61	2.18	3.93	2.62	0.29	0.00	1.02	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	174.01	3.04	4.26	3.04	0.00	0.00	1.83	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	141.96	3.62	6.63	6.03	0.00	0.00	2.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	207.87	1.58	2.71	2.04	0.00	0.00	9.50	1.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	219.56	0.90	4.49	2.70	0.00	0.30	1.20	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	142.99	1.89	4.84	3.31	0.00	0.00	23.61	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	205.76	2.35	2.35	4.06	0.00	0.00	27.53	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	206.14	0.00	3.00	3.00	0.00	0.00	9.01	0.00
Schwann Cells, donor1	11498-119F4	106.82	1.32	1.69	1.50	0.19	0.00	0.19	0.19
Schwann Cells, donor2	11578-120F3	68.05	0.00	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	73.39	3.07	1.97	2.41	0.00	0.44	0.00	0.44
Sebocyte, donor1	11220-116B5	112.29	5.48	4.93	1.10	1.64	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	72.15	3.68	0.46	1.38	0.46	1.38	0.92	0.46
Sebocyte, donor3	11378-118B1	85.74	2.27	0.41	0.21	0.21	0.82	0.21	0.41
Sertoli Cells, donor1	11255-116F4	87.80	6.63	1.66	1.66	0.00	0.00	1.66	1.66
Sertoli Cells, donor2	11333-117F1	70.61	2.82	2.82	0.00	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	84.72	0.97	1.67	3.17	0.09	0.18	0.35	0.09
Skeletal Muscle Cells, donor2	11358-117H8	83.85	0.72	0.72	2.89	0.00	0.00	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	159.68	0.00	1.67	0.84	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	83.26	0.94	1.57	1.26	0.47	0.16	0.16	0.47
Skeletal Muscle Cells, donor5	11455-119A6	79.08	1.49	1.49	0.30	0.15	0.15	0.45	0.45
Skeletal Muscle Cells, donor6	11459-119B1	77.72	0.62	0.31	0.31	0.00	0.00	0.15	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	79.64	2.77	0.88	0.50	0.13	0.13	0.38	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	87.18	2.57	1.85	0.71	0.14	0.14	0.57	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	104.07	1.79	0.50	0.50	0.10	0.20	0.30	0.50
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	81.64	2.95	1.85	2.27	0.34	0.25	0.17	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	120.14	0.72	0.00	0.00	0.00	0.00	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	50.64	1.38	1.93	1.65	0.00	0.00	0.83	0.41
Skin - palm, donor1	10286-104F7	21.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	34.31	1.87	1.01	0.29	0.43	0.14	0.00	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	48.26	6.54	3.27	0.00	0.00	0.00	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	43.49	2.34	0.78	0.39	0.52	0.26	0.13	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	78.54	1.39	2.64	2.36	0.14	0.28	0.56	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	61.47	1.27	1.13	1.41	0.00	0.00	0.00	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	58.78	3.38	2.96	1.48	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	85.29	0.67	1.42	1.12	0.15	0.07	0.30	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	82.39	0.62	1.54	2.47	0.31	0.00	0.31	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	28.46	0.22	0.44	0.22	0.22	0.00	0.00	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	108.75	0.00	1.18	2.35	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	59.23	1.33	0.00	1.99	0.22	0.22	0.00	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	96.48	1.18	1.18	2.76	1.58	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	97.34	1.55	0.00	0.77	0.00	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	49.04	4.00	1.00	1.00	0.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	81.98	1.73	1.33	0.93	0.00	0.27	0.53	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	51.87	1.33	0.89	0.22	0.00	0.00	0.22	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	63.38	1.79	0.77	1.15	0.26	0.00	0.64	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	46.89	1.30	0.98	0.33	0.00	0.00	0.98	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	57.29	0.89	2.36	0.89	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	45.56	1.42	0.28	0.43	0.14	0.43	0.14	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	79.87	2.11	1.46	0.65	0.16	0.00	0.16	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	43.23	0.30	1.22	0.30	0.00	0.00	0.00	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	76.27	0.76	1.77	1.26	0.00	0.00	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	67.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	83.45	1.43	0.95	0.95	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	34.36	0.74	1.18	0.74	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	55.32	2.15	0.65	0.43	0.00	0.00	0.43	0.43
Smooth Muscle Cells - Colonic, donor3	11396-118D1	54.37	1.26	0.84	1.15	0.21	0.00	0.10	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	105.49	2.32	2.17	0.77	0.31	0.93	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	89.46	0.00	1.08	0.00	0.00	0.00	1.08	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	53.79	0.30	1.20	0.00	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	112.66	3.41	2.05	0.00	0.68	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	63.06	1.73	1.10	0.79	0.00	0.16	0.16	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	74.07	1.21	1.31	1.31	0.20	0.00	0.60	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	44.15	0.91	0.46	0.23	0.00	0.00	0.68	0.68
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	70.04	0.00	0.60	0.00	0.00	0.00	1.81	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	85.31	3.44	1.59	0.79	0.26	0.00	0.53	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	58.72	1.07	1.86	1.60	0.27	0.13	0.13	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	61.73	2.00	0.50	1.00	0.25	0.50	0.50	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	44.39	0.25	1.27	1.27	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	82.32	1.06	1.66	1.06	0.45	0.30	0.60	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	78.02	0.75	0.00	0.75	0.00	0.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	142.14	0.00	1.29	1.29	0.00	0.00	1.29	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	159.52	2.79	0.47	3.26	0.00	0.00	0.47	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	76.24	1.01	1.01	0.50	0.00	0.50	1.01	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	49.52	1.25	0.63	2.19	0.31	0.00	0.31	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	54.28	1.47	0.59	1.18	0.00	0.00	0.00	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	66.48	1.50	1.08	1.08	0.08	0.17	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	31.77	0.47	0.00	0.47	0.00	0.00	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	76.71	1.15	2.30	2.16	0.14	0.00	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	97.90	1.53	2.29	1.53	0.51	0.00	0.51	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	84.43	0.38	0.19	3.01	0.00	0.00	0.75	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	59.25	1.96	1.40	1.40	0.14	0.14	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	66.44	2.26	1.68	1.42	0.00	0.00	0.00	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	67.62	0.00	0.95	0.00	0.00	0.00	0.48	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	71.93	1.22	0.98	1.96	0.00	0.00	0.73	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	58.33	1.10	0.22	1.33	0.22	0.00	0.44	0.44
Smooth Muscle Cells - Uterine, donor3	11466-119B8	69.34	0.88	1.17	0.88	0.00	0.00	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	35.96	0.39	0.00	0.78	0.00	0.00	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	29.09	0.53	0.26	0.26	0.00	0.00	0.00	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	28.64	0.74	1.12	0.00	0.00	0.00	0.74	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	43.48	0.36	0.00	0.00	0.00	0.36	1.08	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	39.46	1.14	0.28	0.57	0.28	0.00	0.28	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	68.93	1.18	0.79	0.00	0.00	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	32.25	0.51	1.02	0.25	0.00	0.00	0.51	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	49.52	0.00	0.00	1.20	0.00	0.00	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	31.77	0.00	0.84	0.84	0.00	0.42	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	38.50	0.00	0.92	0.92	0.00	0.00	0.00	0.00
Synoviocyte, donor1	11291-117A4	71.03	1.01	0.84	1.35	0.50	0.50	0.34	0.17
Synoviocyte, donor2	11368-117I9	50.29	1.01	0.67	1.01	0.00	0.50	0.00	0.17
Synoviocyte, donor3	11440-118H9	43.12	0.22	0.89	0.22	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	144.00	1.07	1.79	0.71	0.00	0.36	0.71	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	101.08	0.00	0.00	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	125.04	2.32	3.24	3.24	0.00	0.00	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	70.11	0.79	1.08	1.00	0.00	0.14	0.29	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	99.73	4.25	0.39	0.39	0.00	0.39	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	82.46	0.57	0.00	2.86	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	42.20	0.86	0.98	0.98	0.12	0.12	0.25	0.25
Urethra, donor2	10319-105A4	25.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	75.71	1.86	0.80	0.27	0.00	0.27	0.53	0.00
Urothelial Cells, donor2	11600-120H7	54.88	1.20	0.80	0.80	0.00	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	85.49	1.15	0.46	1.15	0.00	0.00	0.46	0.00
Urothelial cells, donor0	11216-116B1	74.89	1.34	1.11	0.67	0.45	0.22	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	31.14	0.00	0.00	0.89	0.00	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	28.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	26.70	0.00	0.68	1.37	0.00	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	25.83	1.03	1.03	0.00	0.00	0.69	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	22.66	0.58	1.16	1.16	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	22.91	0.00	1.04	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	22.94	0.00	0.92	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	26.47	0.00	0.91	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	74.14	7.90	3.58	2.34	1.97	1.11	0.37	0.37
Wilms' tumor cell line:HFWT	10597-108E3	51.04	0.00	0.88	4.40	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	86.87	1.12	2.51	1.96	0.00	0.00	0.28	0.28
achilles tendon, donor2	10292-104G4	31.00	0.00	2.07	2.07	0.00	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	48.44	1.27	2.04	1.27	0.25	0.00	0.00	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	35.99	0.93	0.46	1.39	0.00	0.00	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	75.02	1.31	1.78	2.61	0.24	0.00	0.00	0.12
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	38.91	1.63	1.63	0.82	0.27	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	39.07	0.56	0.84	0.56	0.00	0.28	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	33.63	0.21	0.21	0.63	0.00	0.00	0.21	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	70.78	1.09	1.09	2.72	0.00	0.00	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	46.71	0.44	0.88	0.00	0.00	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	55.13	1.23	0.41	1.23	0.00	0.00	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	56.30	2.72	1.55	1.16	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	32.38	0.55	0.37	0.74	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	27.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	40.43	0.23	1.16	0.93	0.00	0.00	0.23	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	48.41	0.78	0.26	0.26	0.00	0.00	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	62.83	0.58	0.58	2.34	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	46.01	0.46	0.00	0.46	0.00	0.00	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	32.08	0.00	0.00	0.00	0.00	0.00	0.41	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	34.07	0.00	0.92	0.92	0.00	0.00	0.31	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	37.98	0.43	1.28	2.56	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	46.10	0.30	1.52	1.82	0.00	0.00	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	54.88	0.72	0.72	1.20	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	63.04	1.56	0.89	1.56	0.22	0.45	0.00	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	26.35	0.67	0.33	0.67	0.00	0.00	0.33	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	37.16	1.86	0.00	1.86	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	52.73	1.88	0.00	1.88	0.00	0.38	0.38	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	62.80	0.87	0.87	0.87	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	33.74	0.00	0.00	1.87	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	80.07	1.41	1.65	1.88	0.24	0.24	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	43.43	0.78	0.78	0.62	0.00	0.16	0.62	0.16
adipose, donor1	10184-103D4	75.65	2.35	2.35	7.62	0.00	0.00	2.93	0.00
adipose, donor2	10185-103D5	298.46	0.81	2.03	0.81	0.00	0.00	1.62	0.00
adipose, donor3	10186-103D6	176.72	1.36	2.18	3.81	0.00	0.54	2.18	0.27
adipose, donor4	10187-103D7	134.35	2.60	3.47	0.87	0.00	0.00	1.73	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	79.07	1.58	1.74	2.68	0.00	0.16	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	76.39	0.00	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	45.49	1.20	2.53	2.13	0.00	0.00	0.40	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	86.11	2.50	1.43	0.36	0.00	0.71	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	46.14	1.62	0.70	1.62	0.70	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	90.27	3.72	5.41	1.35	0.34	0.34	0.68	0.00
amniotic membrane cells, donor3	12237-129G5	51.85	2.95	1.47	0.88	0.00	0.29	0.00	0.29
amygdala - adult, donor10196	10167-103B5	93.68	1.19	5.93	3.56	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	79.48	0.81	1.22	1.01	0.00	0.00	0.20	0.20
amygdala, newborn, donor10223	10360-105E9	55.19	1.94	1.29	0.00	0.32	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	90.15	0.51	1.27	1.27	0.00	0.00	0.13	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	72.36	3.09	2.43	1.10	0.00	0.22	0.00	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	97.54	1.67	1.00	2.00	0.00	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	33.34	0.59	1.96	0.39	0.39	0.00	0.00	0.00
appendix, adult	10189-103D9	45.80	0.78	1.16	0.78	0.00	0.00	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	56.06	0.34	1.72	4.47	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	118.21	0.00	0.00	0.00	1.36	0.00	2.72	1.36
astrocytoma cell line:TM-31	10425-106D2	118.65	2.46	4.20	2.46	0.43	0.14	0.14	0.14
b cell line:RPMI1788	10427-106D4	66.47	1.19	0.59	1.04	0.15	0.30	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	77.41	1.11	0.55	0.28	0.00	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	82.76	1.69	1.19	1.29	0.00	0.10	0.20	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	26.61	0.67	1.17	1.00	0.17	0.00	0.17	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	53.13	0.56	1.12	1.12	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	36.50	1.09	0.43	0.33	0.54	0.00	0.11	0.22
blood, adult, pool1	10053-101G8	26.58	0.00	2.21	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	44.53	0.86	0.00	1.71	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	71.53	0.67	1.35	0.00	0.00	0.00	0.00	0.67
brain, adult, donor1	10084-102B3	145.56	0.00	1.03	2.05	0.00	0.00	3.08	0.00
brain, adult, pool1	10012-101C3	83.41	1.11	2.00	0.89	0.11	0.11	0.67	0.00
brain, fetal, pool1	10085-102B4	149.60	0.00	0.00	8.01	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	57.15	4.63	1.32	0.66	1.98	1.65	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	72.65	4.87	3.50	4.87	0.87	0.62	0.37	0.00
breast, adult, donor1	10080-102A8	46.09	0.63	2.53	0.00	0.00	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	42.05	1.02	1.27	0.51	0.00	0.13	0.00	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	96.17	2.16	1.55	3.09	0.62	0.00	0.31	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	61.01	3.68	3.91	1.61	0.46	0.23	0.46	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	64.88	1.69	1.94	1.94	0.00	0.00	0.24	0.73
carcinoid cell line:NCI-H1770	10703-109H1	109.08	0.47	3.76	2.82	0.00	0.00	0.47	0.00
carcinoid cell line:NCI-H727	10735-110B6	167.24	0.98	1.64	1.97	0.22	0.00	0.55	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	122.32	1.58	1.90	1.58	0.00	0.00	0.63	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	144.53	3.73	2.13	4.53	0.53	0.80	0.80	1.33
caudate nucleus - adult, donor10196	10177-103C6	56.41	1.15	0.00	2.30	0.00	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	55.55	0.33	0.67	1.34	0.00	0.00	0.00	0.33
caudate nucleus, adult, donor10258	10379-105H1	55.78	0.00	0.76	1.53	0.00	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	54.93	0.73	0.00	1.10	0.00	0.00	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	180.62	5.83	0.00	0.00	0.00	2.91	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	205.18	1.28	6.62	2.35	0.00	0.21	0.43	1.07
cerebellum, adult, pool1	10083-102B2	140.05	1.38	0.69	1.72	0.00	0.00	0.69	2.41
cerebellum, newborn, donor10223	10357-105E6	113.75	1.66	2.49	4.15	0.00	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	88.75	0.76	1.01	0.76	0.00	0.00	0.76	0.25
cerebrospinal fluid, donor2	10294-104G6	47.51	0.00	0.73	0.00	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	195.98	4.46	3.59	2.73	0.00	0.14	0.00	0.14
cervical cancer cell line:ME-180	10553-107I4	134.40	4.64	1.33	1.49	1.33	0.66	0.00	0.33
cervix, adult, pool1	10013-101C4	45.25	0.73	1.47	0.84	0.21	0.00	0.21	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	89.46	2.09	2.93	2.23	1.11	0.70	0.56	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	32.66	1.31	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	115.70	1.37	1.74	2.49	0.25	0.12	0.37	0.25
choriocarcinoma cell line:SCH	10785-110H2	60.50	2.46	2.09	3.57	0.25	0.12	0.12	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	98.90	0.95	2.37	4.27	0.24	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	35.61	2.28	1.42	2.28	0.85	0.00	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	64.33	1.09	0.70	0.80	0.00	0.10	0.80	0.40
chorionic membrane cells, donor3	12240-129G8	36.82	0.00	1.65	1.10	0.55	0.00	1.10	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	28.27	0.00	0.00	0.00	0.00	0.00	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	41.49	0.58	0.77	0.58	0.19	0.19	0.38	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	32.95	0.00	0.21	0.21	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	53.16	0.00	0.51	1.54	0.26	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	54.91	0.97	1.21	0.73	0.00	0.00	0.24	0.73
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	53.96	0.41	0.81	0.81	0.00	0.00	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	44.76	0.59	0.59	1.18	0.00	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	45.61	0.78	0.52	0.00	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	85.03	1.14	2.51	1.14	0.23	0.00	0.46	0.46
clear cell carcinoma cell line:TEN	10636-108I6	77.73	3.82	2.95	1.39	0.35	0.35	0.35	0.00
colon carcinoma cell line:CACO-2	10513-107D9	69.56	1.28	3.66	2.93	0.18	0.18	0.00	0.18
colon carcinoma cell line:COLO-320	10420-106C6	157.35	6.08	4.18	4.18	0.00	0.00	0.00	0.38
colon, adult, donor1	10082-102B1	69.02	1.19	2.38	0.00	0.00	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	54.40	2.35	0.94	0.94	0.35	0.12	2.59	0.24
colon, fetal, donor1	10070-101I7	51.29	0.62	0.62	1.24	0.00	0.00	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	87.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	33.57	2.97	3.82	0.85	0.85	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	28.53	3.32	2.11	0.91	0.30	0.00	0.15	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	31.30	3.67	3.10	0.71	0.14	0.14	0.14	0.42
corpus callosum, adult, pool1	10042-101F6	76.07	1.22	1.66	0.66	0.22	0.22	0.11	0.00
cruciate ligament, donor2	10295-104G7	28.37	0.00	0.00	0.00	0.00	0.00	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	95.50	0.00	1.61	0.80	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	67.68	1.68	0.96	2.16	0.00	0.00	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	67.05	1.38	1.84	1.15	0.23	0.00	0.46	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	206.95	1.03	2.31	2.82	0.00	0.00	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	118.19	5.54	3.37	2.17	0.48	1.44	0.00	0.00
ductus deferens, adult	10196-103E7	61.30	1.00	1.50	1.00	0.00	0.00	1.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	50.41	2.88	1.44	4.32	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	52.23	2.94	1.47	1.47	0.00	0.00	0.00	0.00
dura mater, adult, donor1	10041-101F5	52.20	2.06	1.32	1.90	0.41	0.41	0.25	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	221.41	2.66	2.00	1.33	9.55	1.33	2.66	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	165.22	12.18	6.16	3.01	35.97	0.86	0.14	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	47.48	0.00	0.62	3.08	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	46.01	0.61	1.51	0.00	0.00	0.00	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	50.02	0.62	0.31	0.31	0.00	0.00	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	43.34	0.00	1.31	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	69.05	1.68	1.34	1.68	0.67	0.00	0.34	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	137.74	0.91	1.45	4.35	0.00	0.00	0.36	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	166.92	8.84	10.29	3.70	3.38	1.13	0.64	1.45
epidermoid carcinoma cell line:A431	10426-106D3	128.50	3.67	1.78	0.56	1.89	1.11	0.22	0.44
epidermoid carcinoma cell line:Ca Ski	10431-106D8	124.50	1.87	2.42	1.54	0.33	0.11	0.11	0.00
epididymis, adult	10197-103E8	43.54	0.63	0.63	1.67	0.42	0.21	2.51	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	60.50	1.95	1.06	1.60	0.53	0.18	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	40.90	2.75	0.79	1.18	0.79	0.39	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	125.81	6.42	7.21	5.64	0.26	0.13	0.13	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	143.69	6.30	8.56	7.58	0.79	0.39	0.20	1.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	142.73	5.04	6.83	4.48	0.45	0.00	0.22	1.68
esophagus, adult, pool1	10015-101C6	46.72	1.27	1.38	0.53	0.11	0.11	0.32	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	312.84	127.74	24.17	4.01	82.53	15.65	0.75	0.75
eye - muscle inferior rectus, donor1	10272-104E2	38.63	0.00	4.83	0.00	2.41	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	56.81	0.00	0.00	2.10	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	55.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	55.03	1.15	0.00	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	26.23	0.00	1.46	2.91	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	75.76	0.51	0.76	1.02	0.00	0.00	0.00	1.78
fibrosarcoma cell line:HT-1080	10758-110E2	44.11	0.90	0.51	1.28	0.00	0.26	0.00	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	37.04	0.95	1.42	1.42	0.00	0.00	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	136.80	0.66	2.25	1.50	0.09	0.09	0.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	119.50	7.21	5.70	2.10	0.90	0.00	0.60	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	45.44	0.64	0.73	0.73	0.18	0.00	0.09	0.00
gall bladder, adult	10198-103E9	45.63	2.17	0.48	1.21	0.48	0.00	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	33.82	1.61	1.61	0.54	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	26.14	1.12	1.12	0.37	0.00	0.37	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	87.02	6.34	4.44	2.11	0.00	0.42	0.21	1.69
gastric adenocarcinoma cell line:MKN45	10612-108F9	53.38	0.58	0.97	2.32	0.00	0.00	0.19	0.19
gastric cancer cell line:AZ521	10549-107H9	68.70	2.30	1.97	4.26	0.16	0.00	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	160.16	2.75	4.58	0.92	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	59.86	0.46	0.69	0.91	0.00	0.00	0.69	0.00
giant cell carcinoma cell line:LU65	10487-107B1	26.05	0.80	1.15	1.15	0.00	0.00	0.11	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	48.57	1.54	0.84	1.12	0.28	0.00	0.00	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	103.76	4.74	2.00	1.50	1.00	0.25	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	61.33	2.96	2.01	2.53	0.00	0.11	0.11	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	62.50	2.67	2.95	2.39	0.00	0.42	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	80.68	1.66	2.43	1.88	0.22	0.22	0.00	0.00
glioma cell line:GI-1	10413-106B8	43.64	2.05	2.05	2.05	0.00	0.29	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	46.65	2.19	0.00	0.00	1.46	0.00	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	60.29	0.73	2.20	0.98	0.00	0.00	0.24	0.24
globus pallidus, adult, donor10258	10367-105F7	43.81	0.00	0.00	1.37	0.00	0.00	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	51.69	0.53	0.53	1.07	1.07	0.00	0.53	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	119.91	2.45	0.00	2.45	2.45	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	32.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	20.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	70.72	1.28	0.96	0.32	0.32	0.32	0.00	0.32
hIPS +CCl2, biol_rep1	14383-156B9	112.02	5.51	4.13	6.43	0.00	0.46	0.00	0.92
hIPS +CCl2, biol_rep2	14384-156C1	104.71	6.86	3.66	7.77	0.46	0.46	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	123.02	3.22	3.86	5.15	0.00	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	80.49	1.44	11.50	7.19	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	90.53	4.80	3.43	3.43	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	71.73	0.00	0.00	0.00	0.00	0.00	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	37.07	2.59	0.86	0.86	0.86	0.57	0.00	0.29
heart - mitral valve, adult	10205-103F7	65.77	0.90	0.30	0.60	0.90	0.00	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	75.30	1.05	0.00	0.78	0.52	0.00	0.78	0.00
heart - tricuspid valve, adult	10207-103F9	65.78	0.00	0.00	0.00	0.83	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	106.52	1.63	1.22	0.41	0.20	0.20	0.41	1.22
heart, adult, diseased, donor1	10051-101G6	124.34	0.85	1.28	0.43	0.00	0.00	0.43	0.43
heart, adult, pool1	10016-101C7	98.20	0.00	0.69	0.69	0.00	0.00	1.38	0.23
heart, fetal, pool1	10046-101G1	141.60	1.13	1.64	1.03	0.31	0.00	0.21	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	62.94	0.62	0.62	0.31	0.00	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	41.62	0.00	0.00	1.19	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	75.36	6.63	5.30	4.64	0.77	0.44	0.33	0.66
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	79.26	5.46	5.34	4.01	0.49	0.24	0.12	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	84.38	5.15	6.27	4.35	0.71	0.40	0.20	0.71
hepatoma cell line:Li-7	10484-107A7	70.96	2.78	2.89	2.89	0.00	0.00	0.44	0.00
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	42.01	0.80	0.90	0.90	0.20	0.10	0.10	0.10
hippocampus - adult, donor10196	10169-103B7	65.30	0.95	0.00	1.89	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	84.50	0.61	2.25	0.82	0.00	0.00	0.41	0.00
hippocampus, adult, donor10258	10374-105G5	83.16	1.00	0.00	1.00	0.50	0.50	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	84.95	0.35	0.00	1.41	0.35	0.00	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	66.53	3.66	6.71	4.88	0.00	1.83	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	84.04	3.93	4.12	0.59	0.20	0.79	0.39	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	81.50	4.06	4.06	2.29	1.52	0.76	0.25	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	204.12	1.13	2.26	2.26	0.00	0.00	3.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	240.65	1.55	3.61	4.65	0.00	0.00	4.39	4.39
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	166.27	0.76	1.90	1.90	0.00	0.00	3.80	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	138.39	3.50	1.46	5.55	0.58	0.00	4.38	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	185.48	1.94	1.29	3.88	0.00	0.00	2.37	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	150.56	2.09	1.25	5.00	0.42	0.00	2.50	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	92.59	1.89	3.32	4.26	0.00	0.24	0.71	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	139.66	1.93	2.09	5.46	0.00	0.32	1.45	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	103.02	2.02	0.67	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	79.49	4.38	4.38	2.19	0.63	0.16	0.47	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	85.49	3.93	4.42	3.93	0.49	0.00	0.49	1.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	61.97	10.47	6.11	1.75	0.00	0.00	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	302.40	1.15	1.91	3.63	0.38	0.00	3.44	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	314.84	0.00	2.18	3.05	0.00	0.00	1.31	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	187.91	0.50	3.00	3.50	0.00	0.00	4.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	239.26	0.75	2.26	0.94	0.00	0.00	3.58	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	237.36	1.36	3.64	4.55	0.45	0.00	3.18	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	197.97	0.63	2.51	2.82	0.00	0.00	2.19	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	154.48	1.80	3.92	2.78	0.16	0.16	0.33	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	157.35	2.32	3.48	3.77	0.00	0.00	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	145.28	2.99	1.20	3.59	0.30	0.30	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	89.97	3.69	4.25	1.48	0.74	0.00	0.37	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	88.15	5.14	4.85	1.71	0.29	1.14	0.86	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	62.06	6.12	4.08	1.22	1.63	0.82	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	155.97	2.82	4.58	4.93	0.00	0.00	1.41	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	177.06	2.85	2.22	4.43	0.00	0.00	3.48	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	140.11	2.12	2.12	3.03	0.00	0.30	0.30	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	140.14	1.03	2.07	2.59	0.00	0.52	2.07	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	138.81	1.33	1.99	2.66	0.00	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	88.76	2.05	2.05	2.57	0.00	0.26	1.54	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	93.31	1.79	4.35	3.58	0.00	0.26	1.79	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	111.31	3.03	3.03	2.27	0.00	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	90.74	3.02	1.68	3.36	0.34	0.00	0.67	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	110.13	5.31	4.83	2.17	0.00	0.48	0.24	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	69.52	10.25	3.57	4.46	0.45	0.89	0.89	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	83.90	6.34	3.90	2.44	0.00	0.98	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	180.31	0.92	1.83	3.06	0.00	0.00	2.44	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	48.80	3.25	13.01	3.25	0.00	0.00	6.51	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	111.53	3.31	2.65	3.97	0.00	0.00	3.64	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	178.42	1.09	2.19	4.93	0.55	0.55	1.09	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	136.43	2.17	2.53	2.90	0.00	0.00	2.17	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	113.17	1.07	2.14	3.20	0.00	0.36	2.85	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	126.50	4.77	2.39	0.00	0.00	0.00	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	113.22	3.52	3.25	3.52	0.41	0.27	2.44	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	89.44	2.16	2.16	1.89	0.27	0.27	1.89	0.27
immature langerhans cells, donor1	11904-125F5	38.99	3.87	2.66	0.24	1.45	0.73	0.00	0.00
immature langerhans cells, donor2	11905-125F6	71.29	12.67	3.17	0.00	9.51	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	164.00	1.99	3.31	2.37	0.09	0.00	0.09	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	88.44	2.60	1.63	2.93	0.00	0.00	0.65	0.65
kidney, adult, pool1	10017-101C8	63.38	4.51	1.80	1.00	0.60	0.70	0.00	0.10
kidney, fetal, pool1	10045-101F9	100.80	4.24	3.25	1.41	0.50	0.14	0.21	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	50.28	0.43	0.28	0.99	0.14	0.00	0.28	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	65.80	2.90	2.49	2.90	0.00	0.00	0.14	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	76.70	0.73	0.92	1.28	0.00	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	71.92	0.00	0.54	1.09	0.00	0.00	1.09	1.09
left ventricle, adult, donor1	10078-102A6	59.67	0.00	0.00	0.51	0.00	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	69.50	16.96	2.46	1.92	2.74	2.19	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	54.97	0.00	1.08	0.36	0.00	0.72	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	43.48	1.09	2.17	0.00	0.54	0.54	1.63	0.00
leiomyoma cell line:15425	10571-108B4	64.35	1.70	0.73	1.46	0.00	0.00	0.49	0.49
leiomyosarcoma cell line:Hs 5.T	10722-110A2	88.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	75.28	3.14	1.05	1.05	0.00	1.05	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	53.36	0.94	0.83	0.35	0.00	0.12	0.12	0.12
liposarcoma cell line:KMLS-1	10782-110G8	87.79	1.87	2.81	1.56	0.00	0.31	0.31	0.47
liposarcoma cell line:SW 872	10726-110A6	85.04	2.80	3.29	2.68	0.00	0.00	0.12	0.12
liver, adult, pool1	10018-101C9	31.44	2.11	1.62	0.32	0.00	0.32	0.81	0.32
liver, fetal, pool1	10086-102B5	52.68	1.88	1.88	0.94	0.00	0.94	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	67.81	1.02	1.17	0.73	0.00	0.00	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	50.94	0.74	2.40	1.66	0.18	0.00	0.00	0.74
locus coeruleus, adult, donor10258	10375-105G6	42.60	0.28	0.85	1.41	0.28	0.28	0.85	0.28
locus coeruleus, newborn, donor10223	10362-105F2	38.70	1.26	0.42	1.26	0.00	0.00	0.84	0.84
lung adenocarcinoma cell line:A549	10499-107C4	48.99	0.97	1.52	2.35	0.00	0.00	0.14	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	19.99	0.69	0.00	0.69	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	39.28	0.26	0.53	0.40	0.00	0.13	0.13	0.13
lung, adult, pool1	10019-101D1	45.12	2.13	0.83	0.47	0.47	0.00	0.24	0.00
lung, fetal, donor1	10068-101I5	69.92	0.86	1.71	1.14	0.29	0.00	0.00	0.00
lung, right lower lobe, adult, donor1	10075-102A3	59.11	0.46	0.00	0.46	0.00	0.00	1.37	0.00
lymph node, adult, donor1	10077-102A5	25.09	0.47	0.47	0.95	0.00	0.00	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	42.08	0.88	0.66	1.10	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	74.86	0.60	1.36	1.51	0.00	0.00	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	45.87	0.00	0.00	1.70	0.00	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	91.91	1.78	0.89	0.44	0.00	0.44	0.89	0.00
mature adipocyte, donor2	12232-129F9	74.09	0.83	0.21	0.62	0.21	0.00	1.04	0.00
mature adipocyte, donor3	12233-129G1	74.20	1.19	1.19	1.66	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	70.02	0.53	0.79	1.32	0.00	0.26	0.00	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	99.12	2.38	0.71	5.48	0.00	0.00	0.95	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	91.37	0.00	3.38	3.38	2.26	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	89.75	0.92	2.02	2.21	0.00	0.00	0.92	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	81.33	0.32	0.32	0.95	0.00	0.00	0.00	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	72.08	1.28	0.43	0.85	0.85	0.43	1.28	1.71
medial temporal gyrus - adult, donor10196	10183-103D3	111.38	1.52	3.04	1.52	0.00	0.34	1.86	5.40
medial temporal gyrus, adult, donor10252	10156-103A3	85.95	0.85	2.33	1.27	0.21	0.00	0.00	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	53.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	104.45	2.15	0.36	3.23	0.72	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	42.18	1.30	1.95	1.30	0.65	0.00	0.65	0.00
medulla oblongata, adult, donor10252	10155-103A2	54.03	0.31	1.39	1.24	0.00	0.00	0.15	0.46
medulla oblongata, adult, pool1	10038-101F2	77.79	0.98	0.98	1.22	0.24	0.08	0.08	0.24
medulla oblongata, newborn, donor10223	10361-105F1	53.12	0.35	0.69	0.00	0.00	0.00	0.69	0.00
medulloblastoma cell line:D283 Med	10838-111E1	119.12	1.33	1.55	1.55	0.00	0.22	0.66	0.44
medulloblastoma cell line:ONS-76	10759-110E3	53.43	1.71	1.59	1.47	0.00	0.00	0.00	0.24
melanoma cell line:COLO 679	10514-107E1	100.05	2.16	0.72	1.72	0.29	0.14	0.86	0.14
melanoma cell line:G-361	10465-106H6	124.33	4.89	4.89	1.63	1.90	1.09	1.36	0.00
meningioma cell line:HKBMM	10691-109F7	49.93	1.09	0.54	0.90	0.00	0.18	0.72	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	84.59	1.76	1.76	6.17	0.00	0.00	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	88.91	1.56	2.85	2.33	0.00	0.26	0.00	0.78
mesenchymal precursor cell - adipose, donor1	11747-123G1	77.02	1.69	2.30	1.38	0.15	0.15	0.00	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	65.80	0.36	0.73	1.27	0.00	0.55	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	53.83	0.83	1.66	0.41	0.00	0.00	0.41	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	44.25	0.14	0.84	0.42	0.00	0.00	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	43.71	0.77	0.77	1.16	0.00	0.19	0.19	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	56.91	0.00	0.00	2.08	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	54.75	0.00	1.20	1.54	0.00	0.17	0.34	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	41.41	1.04	0.81	1.73	0.00	0.00	0.46	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	57.43	1.33	0.93	1.46	0.40	0.13	0.00	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	45.91	0.95	1.35	0.54	0.27	0.14	0.27	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	59.32	0.43	0.43	1.00	0.28	0.14	0.14	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	44.13	0.33	0.66	1.32	0.00	0.33	0.33	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	56.59	0.55	1.11	1.25	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	47.13	0.70	1.40	0.00	0.00	0.00	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	46.75	0.82	0.61	0.61	0.00	0.00	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	46.01	0.72	2.16	1.80	0.36	0.00	0.72	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	52.04	1.34	1.03	1.03	0.10	0.10	0.00	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	50.39	1.82	1.14	0.68	0.46	0.46	0.23	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	52.44	1.26	1.68	0.84	0.00	0.42	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	45.13	0.90	0.60	1.20	0.15	0.00	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	52.52	1.93	2.89	1.93	0.18	0.00	0.35	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	40.50	0.37	0.00	1.47	0.00	0.00	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	60.38	0.00	0.86	0.57	0.00	0.00	1.14	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	108.62	1.26	2.53	2.53	0.00	0.00	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	49.32	0.46	0.46	0.46	0.00	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	48.60	1.28	1.28	1.28	0.26	0.26	0.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	51.04	1.05	0.79	0.79	0.00	0.52	0.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	51.76	1.54	1.54	0.62	0.31	0.31	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	40.95	1.41	0.94	0.47	0.24	0.24	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	50.43	2.03	1.69	0.68	0.68	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	50.30	1.18	0.39	0.39	0.39	0.39	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	42.63	1.85	0.93	1.39	0.46	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	63.45	1.44	0.58	0.87	0.00	0.29	1.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	45.51	1.12	0.89	0.89	0.22	0.22	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	42.30	1.20	0.72	2.40	0.48	0.00	0.24	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	57.20	0.73	0.73	0.73	0.00	1.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	36.25	1.01	0.67	1.01	0.00	0.67	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	54.45	1.23	0.00	1.23	0.00	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	47.68	0.00	2.58	0.43	0.86	0.00	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	68.36	0.00	0.00	2.73	0.00	0.00	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	41.32	5.16	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	46.77	0.65	0.32	1.95	0.00	0.00	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	52.38	1.45	0.00	0.00	1.45	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	69.83	0.53	0.00	1.60	0.00	1.07	1.60	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	49.07	0.82	0.82	0.82	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	50.53	0.78	0.78	0.78	0.00	0.00	0.00	0.78
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	48.27	0.00	0.00	2.10	0.00	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	44.71	1.99	0.99	0.99	0.00	0.00	1.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	47.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	45.66	0.00	0.00	0.00	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	67.02	0.00	2.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	57.00	0.63	0.63	3.80	0.00	1.27	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	46.91	0.69	0.34	0.69	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	36.54	0.00	0.00	2.15	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	55.89	3.99	0.00	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	42.78	0.41	0.41	0.81	0.41	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	45.28	0.79	0.79	0.79	0.00	0.00	1.59	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	38.32	0.59	0.00	1.18	0.00	0.59	0.59	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	32.73	0.31	0.00	0.94	0.00	0.31	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	41.44	0.00	0.00	0.00	1.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	54.40	2.37	0.00	0.00	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	46.22	2.57	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	57.14	1.38	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	71.75	0.99	0.99	1.98	0.00	0.49	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	74.02	0.00	0.00	5.61	1.12	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	76.96	1.27	0.64	1.27	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	102.76	2.01	2.82	2.82	0.00	0.40	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	93.77	2.18	2.18	0.00	0.00	0.00	2.18	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	133.04	1.27	5.07	1.27	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	84.36	0.00	0.00	0.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	94.90	0.00	4.52	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	95.55	4.12	3.29	2.47	0.00	0.82	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	52.19	1.19	0.40	1.39	0.00	0.20	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	59.71	0.97	0.65	1.62	0.32	0.00	0.97	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	72.32	0.00	1.02	1.02	1.02	0.00	1.02	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	32.50	1.55	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	98.28	2.83	1.65	0.94	0.00	0.00	0.24	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	68.58	10.66	5.33	2.55	2.55	2.55	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	51.28	4.27	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	29.39	2.36	0.62	0.62	0.62	0.51	0.21	0.10
mesothelioma cell line:Mero-25	10850-111F4	132.31	2.50	3.40	1.36	1.13	1.36	0.45	0.23
mesothelioma cell line:Mero-41	10851-111F5	78.97	2.44	0.98	0.98	0.24	0.00	0.49	0.00
mesothelioma cell line:Mero-48a	10852-111F6	75.29	1.33	1.77	1.55	0.00	0.44	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	85.41	2.37	1.58	1.31	0.26	0.00	0.26	0.00
mesothelioma cell line:Mero-83	10854-111F8	73.54	3.40	1.53	1.53	0.17	0.17	1.53	0.17
mesothelioma cell line:Mero-84	10855-111F9	77.10	2.78	3.29	0.51	0.51	0.25	1.26	0.25
mesothelioma cell line:Mero-95	10856-111G1	63.15	2.90	2.48	1.04	0.00	0.00	0.21	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	60.96	1.49	1.99	1.99	0.17	0.00	0.17	0.00
mesothelioma cell line:NCI-H226	10846-111E9	48.87	3.26	2.53	1.09	0.36	0.90	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	49.54	2.73	2.22	2.05	0.17	0.00	0.17	0.00
mesothelioma cell line:NCI-H28	10845-111E8	60.05	4.83	5.09	2.29	0.51	0.00	0.51	0.51
mesothelioma cell line:No36	10857-111G2	70.13	7.18	3.59	1.30	0.00	0.00	0.98	0.00
mesothelioma cell line:ONE58	10858-111G3	81.83	1.90	1.63	1.90	0.00	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	23.22	0.38	0.19	0.19	0.00	0.00	0.19	0.00
migratory langerhans cells, donor2	11902-125F3	29.43	0.37	0.24	0.85	0.00	0.12	0.00	0.24
migratory langerhans cells, donor3	11903-125F4	32.49	0.18	0.54	0.72	0.18	0.36	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	102.84	0.33	2.61	0.98	0.00	0.00	0.98	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	83.93	1.27	0.64	0.42	0.64	0.21	0.21	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	64.04	0.92	0.46	0.69	0.00	0.00	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	23.22	0.57	1.52	0.95	0.00	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	82.60	1.11	2.03	1.48	0.00	0.00	0.00	0.00
myeloma cell line:PCM6	10474-106I6	26.88	0.59	0.79	0.40	0.20	0.00	0.20	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	44.64	1.01	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	79.24	1.18	3.33	3.33	0.00	0.20	0.39	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	85.24	0.67	1.00	1.78	0.00	0.00	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	66.55	0.81	0.88	1.10	0.00	0.00	0.22	0.07
nasal epithelial cells, donor2	12227-129F4	66.79	1.10	2.76	1.10	0.00	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	91.33	0.46	0.23	3.45	0.00	0.00	0.23	0.23
neuroblastoma cell line:NB-1	10539-107G8	144.99	2.81	3.74	2.62	0.00	0.19	0.37	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	110.08	0.42	2.74	4.64	0.00	0.00	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	97.65	0.56	0.93	3.91	0.00	0.00	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	60.73	0.71	1.66	3.32	0.00	0.00	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	88.38	1.11	0.95	2.53	0.32	0.00	0.16	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	98.82	2.01	3.22	1.81	0.00	0.00	0.20	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	90.28	5.09	0.64	3.18	0.00	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	66.28	0.80	0.00	0.53	0.00	0.00	0.00	0.00
neutrophil PMN, donor1	12133-128D9	59.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	9.47	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	79.15	0.68	3.38	1.01	0.00	0.34	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	49.63	0.00	0.00	0.80	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	65.72	2.24	0.96	0.00	0.64	0.64	0.32	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	56.76	0.53	1.05	0.79	0.00	0.26	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	107.33	1.69	2.34	1.22	0.09	0.19	0.09	0.28
occipital cortex - adult, donor10196	10172-103C1	117.44	2.06	2.06	2.06	0.00	0.00	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	94.20	1.34	2.95	1.61	0.00	0.00	0.54	0.54
occipital cortex, newborn, donor10223	10355-105E4	133.93	1.46	0.36	1.46	0.36	0.36	0.36	0.36
occipital lobe, adult, donor1	10076-102A4	161.64	1.31	1.84	1.31	0.00	0.00	2.89	0.26
occipital lobe, fetal, donor1	10073-102A1	127.44	0.86	1.72	1.29	0.00	0.00	0.00	1.29
occipital pole, adult, pool1	10036-101E9	153.98	0.71	2.21	2.37	0.00	0.16	0.08	0.24
olfactory region, adult	10195-103E6	75.85	0.76	0.76	1.72	0.00	0.00	0.76	0.38
optic nerve, donor1	10277-104E7	86.05	0.00	4.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	58.43	2.39	2.39	1.94	0.11	0.46	0.11	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	63.61	0.41	1.51	0.69	0.14	0.00	0.27	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	38.44	0.68	1.19	0.17	0.17	0.17	0.51	0.34
oral squamous cell carcinoma cell line:SAS	10544-107H4	189.43	0.92	2.19	1.16	0.00	0.23	0.81	0.46
osteoclastoma cell line:Hs 706.T	10704-109H2	77.90	1.76	2.06	2.06	0.29	0.59	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	38.31	0.00	2.80	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	75.49	4.24	2.76	2.12	0.21	0.00	0.00	0.00
ovary, adult, pool1	10020-101D2	51.36	1.14	0.87	0.26	0.26	0.00	0.44	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	182.04	3.30	2.93	3.12	0.18	0.00	0.55	0.37
pancreas, adult, donor1	10049-101G4	48.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	93.36	1.40	1.12	1.96	0.00	0.00	0.56	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	81.43	2.04	0.51	1.70	0.17	0.00	0.34	0.85
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	53.98	0.99	2.32	1.49	0.99	0.99	0.17	0.17
paracentral gyrus, adult, pool1	10035-101E8	146.80	1.01	2.47	2.20	0.27	0.09	0.18	0.27
parietal cortex, adult, donor10258	10373-105G4	77.07	0.00	0.73	3.67	0.73	0.00	0.73	0.00
parietal lobe - adult, donor10196	10171-103B9	65.83	0.00	0.94	4.70	0.00	0.00	0.94	0.00
parietal lobe, adult, donor10252	10157-103A4	88.36	0.29	2.57	1.71	0.00	0.00	0.29	0.86
parietal lobe, adult, pool1	10034-101E7	134.21	1.59	2.11	2.03	0.00	0.00	0.18	0.09
parietal lobe, fetal, donor1	10072-101I9	110.56	2.91	0.97	2.91	0.00	0.97	0.97	0.97
parietal lobe, newborn, donor10223	10356-105E5	121.88	0.37	1.50	2.62	1.50	0.00	0.75	0.75
parotid gland, adult	10199-103F1	78.32	1.85	0.62	1.23	0.00	0.00	1.23	0.62
penis, adult	10200-103F2	58.01	0.00	1.07	1.07	0.00	0.00	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	82.74	1.49	0.56	1.30	0.00	0.19	0.19	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	50.26	1.75	1.31	0.58	0.00	0.00	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	46.44	0.00	0.00	1.29	0.00	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	65.14	1.78	0.59	1.18	0.00	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	45.78	0.00	0.63	0.63	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	53.63	3.04	1.01	1.01	0.00	0.00	1.01	0.00
pituitary gland, adult, donor10252	10162-103A9	79.22	1.04	2.61	1.04	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	33.20	0.85	4.26	1.70	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	58.16	1.83	0.97	1.40	0.00	0.11	0.54	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	46.35	0.53	0.93	0.79	0.00	0.00	0.13	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	108.32	3.11	2.18	1.09	0.47	0.16	0.16	0.16
pons, adult, pool1	10033-101E6	105.52	1.64	2.93	0.95	0.17	0.17	0.00	0.17
postcentral gyrus, adult, pool1	10032-101E5	143.05	0.70	2.96	2.35	0.17	0.09	0.35	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	96.20	0.00	0.00	0.00	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	46.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	54.33	2.48	1.75	1.17	0.00	0.00	0.15	0.00
prostate cancer cell line:PC-3	10439-106E7	122.70	3.63	4.72	4.36	0.00	0.18	0.00	0.00
prostate, adult, pool1	10022-101D4	31.65	0.91	1.09	0.63	0.00	0.09	0.18	0.00
putamen, adult, donor10196	10176-103C5	67.28	0.71	1.42	0.47	0.00	0.00	0.24	0.24
putamen, adult, donor10252	10152-102I8	54.90	0.00	0.00	3.92	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	67.75	3.28	1.09	5.46	0.00	0.00	0.00	2.19
putamen, adult, donor10258, tech_rep2	10372-105G3	64.03	0.72	1.21	1.21	0.00	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	38.23	0.75	0.75	0.75	0.75	0.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	66.04	1.75	1.16	0.87	0.29	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	89.02	1.39	0.00	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	63.18	1.48	2.12	1.91	0.00	0.21	0.00	0.64
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	43.91	0.41	1.24	2.07	0.00	0.00	0.41	0.41
retina, adult, pool1	10030-101E3	60.93	0.60	0.89	1.89	0.00	0.00	0.00	0.10
retinoblastoma cell line:Y79	10475-106I7	70.67	1.04	2.34	1.82	0.00	0.26	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	79.67	2.70	1.84	1.11	0.25	0.12	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	84.92	1.69	0.56	1.69	0.00	0.00	0.00	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	50.02	0.76	0.00	0.00	0.00	0.00	0.00	0.00
salivary acinar cells, donor1	11771-123I7	52.28	5.18	2.10	0.81	0.32	0.16	0.16	0.00
salivary acinar cells, donor2	11772-123I8	61.00	5.37	2.75	1.10	0.83	0.96	0.41	0.55
salivary acinar cells, donor3	11773-123I9	46.34	1.32	1.32	0.66	0.00	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	58.91	0.00	2.29	2.29	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	32.97	0.42	0.93	1.52	0.00	0.00	0.00	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	29.15	0.71	0.59	1.65	0.00	0.00	0.00	0.00
seminal vesicle, adult	10201-103F3	55.55	1.06	0.53	0.53	1.06	0.00	0.53	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	49.56	7.77	5.59	1.21	1.46	0.49	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	67.19	1.51	0.75	0.50	0.00	0.00	0.00	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	85.30	3.01	1.00	3.01	0.00	0.00	0.00	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	115.78	17.73	7.39	2.15	3.90	1.21	0.00	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	128.99	0.66	1.66	1.11	0.00	0.44	0.00	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	39.61	1.94	1.55	1.16	0.26	0.13	0.26	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	46.11	0.71	0.00	0.71	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	164.31	0.12	0.60	0.96	0.12	0.00	7.20	0.12
skeletal muscle, fetal, donor1	10066-101I3	76.38	0.00	2.01	4.02	0.00	0.00	1.01	1.01
skin, adult, donor1	10074-102A2	67.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	41.03	0.63	1.89	0.63	0.00	0.00	2.52	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	149.08	1.00	1.67	0.67	0.00	0.00	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	95.19	2.52	2.52	5.36	0.00	0.00	0.95	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	110.83	1.16	2.70	3.47	0.00	0.00	0.39	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	85.05	1.32	2.14	0.82	0.00	0.16	0.33	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	166.96	0.80	0.80	2.09	0.00	0.00	0.16	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	138.60	1.09	1.09	2.62	0.00	0.00	0.00	0.65
small intestine, adult, pool1	10024-101D6	56.85	1.55	1.43	1.31	0.00	0.00	0.24	0.00
small intestine, fetal, donor1	10064-101I1	35.13	0.00	0.98	0.98	0.00	0.00	0.25	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	85.65	0.00	2.05	0.51	0.00	0.00	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	27.65	0.78	0.00	0.00	0.00	0.00	0.52	0.26
somatostatinoma cell line:QGP-1	10781-110G7	49.32	1.07	0.80	0.54	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	48.40	1.38	1.61	1.15	0.00	0.00	0.00	0.92
spinal cord, adult, donor10252	10159-103A6	34.30	0.00	2.37	1.18	0.00	0.39	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	24.90	0.69	1.38	1.38	0.00	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	126.85	0.00	1.83	1.22	0.61	0.00	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	45.00	0.46	1.38	1.38	0.46	0.00	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	57.35	1.05	0.60	0.60	0.00	0.15	0.00	0.15
spleen, adult, pool1	10025-101D7	33.15	0.44	0.33	1.10	0.00	0.00	0.11	0.00
spleen, fetal, pool1	10044-101F8	50.69	0.48	1.27	0.48	0.08	0.00	0.08	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	34.26	0.72	0.72	1.66	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	42.91	0.57	1.14	0.19	0.19	0.00	0.38	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	101.34	1.05	2.80	0.70	0.00	0.00	0.35	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	64.11	0.00	0.39	0.00	0.00	0.39	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	26.90	0.79	0.79	1.01	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	51.68	1.27	0.42	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	101.54	0.42	1.69	1.69	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	61.94	1.07	0.00	0.00	1.07	1.07	0.00	0.00
submaxillary gland, adult	10202-103F4	48.42	0.00	0.00	0.00	0.00	0.00	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	41.75	0.62	2.08	1.04	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	73.97	0.00	1.03	0.00	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	31.09	0.71	0.00	0.71	0.71	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	124.03	2.06	2.75	4.81	0.23	0.00	0.92	0.00
temporal lobe, adult, pool1	10031-101E4	169.12	1.95	3.98	2.46	0.00	0.25	0.25	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	129.63	0.00	4.27	3.56	0.00	0.00	0.71	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	130.54	0.88	3.08	2.20	0.00	0.44	1.32	1.32
tenocyte, donor1	11763-123H8	68.07	1.05	2.09	1.05	0.35	0.35	0.70	1.05
tenocyte, donor2	11765-123I1	57.99	1.53	3.05	1.14	0.38	0.38	0.00	0.38
tenocyte, donor3	11768-123I4	75.62	1.11	0.74	1.48	0.00	0.37	0.00	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	118.29	1.87	3.06	7.14	0.00	0.17	0.17	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	101.28	3.39	4.78	4.16	0.00	0.15	0.77	0.46
teratocarcinoma cell line:PA-1	10807-111A6	81.52	1.24	2.79	2.79	0.00	0.00	0.46	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	58.52	4.06	3.17	1.90	0.76	0.13	0.13	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	109.67	5.67	4.16	3.40	0.00	0.00	0.76	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	110.26	5.45	3.60	1.53	0.55	0.65	0.65	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	53.42	2.61	1.95	0.33	0.33	0.00	0.65	1.63
testis, adult, pool1	10026-101D8	67.43	9.45	3.22	2.36	8.91	3.01	3.44	0.11
testis, adult, pool2	10096-102C6	101.95	14.89	7.67	6.32	22.55	6.77	0.90	0.90
thalamus - adult, donor10196	10168-103B6	55.20	1.10	5.52	2.21	0.00	0.00	1.10	0.00
thalamus, adult, donor10252	10154-103A1	54.86	0.78	1.56	1.56	0.00	0.00	0.47	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	98.54	1.54	3.08	1.54	0.00	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	62.75	0.99	1.48	1.32	0.16	0.16	0.16	1.15
thalamus, newborn, donor10223	10366-105F6	84.57	6.90	6.90	0.00	0.58	1.15	0.00	0.00
throat, adult	10209-103G2	87.88	1.25	2.25	1.25	0.25	0.00	1.75	0.50
throat, fetal, donor1	10061-101H7	57.89	1.83	1.22	0.91	0.00	0.00	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	98.97	0.60	1.19	2.58	0.20	0.20	0.20	0.00
thymus, adult, pool1	10027-101D9	38.08	0.70	0.80	0.89	0.00	0.10	0.20	0.00
thymus, fetal, pool1	10043-101F7	63.28	1.35	1.56	1.66	0.21	0.21	0.10	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	31.64	1.46	0.13	0.13	0.13	0.13	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	79.90	0.56	0.98	0.98	0.00	0.00	0.14	0.00
thyroid, adult, pool1	10028-101E1	73.25	1.87	2.15	1.40	0.00	0.00	0.47	0.09
thyroid, fetal, donor1	10060-101H6	67.50	2.37	2.11	0.79	0.26	0.00	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	108.15	0.70	1.40	0.70	0.70	0.00	1.16	0.70
tongue, fetal, donor1	10059-101H5	157.64	0.39	1.18	1.18	0.39	0.00	1.18	3.15
tonsil, adult, pool1	10047-101G2	50.59	1.20	1.60	1.40	0.40	0.20	0.00	0.10
trachea, adult, pool1	10029-101E2	49.24	1.64	1.47	0.74	0.16	0.00	0.25	0.08
trachea, fetal, donor1	10058-101H4	58.86	1.54	0.77	0.38	0.38	0.00	1.15	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	59.87	0.71	0.00	1.06	0.00	0.35	0.00	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	77.71	1.42	2.33	2.03	0.30	0.10	0.41	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	56.41	1.57	1.41	0.31	0.00	0.00	0.47	0.00
tridermal teratoma cell line:HGRT	10694-109G1	28.54	0.00	1.90	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	34.37	0.59	0.59	1.19	0.08	0.00	0.17	0.00
umbilical cord, fetal, donor1	10057-101H3	68.85	0.00	4.17	0.00	2.09	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	41.12	0.85	0.85	1.02	0.17	0.00	0.00	0.17
uterus, fetal, donor1	10055-101H1	72.18	1.54	0.00	1.02	0.00	0.00	0.00	1.54
vagina, adult	10204-103F6	31.02	0.00	0.65	0.65	0.00	0.00	1.29	0.00
vein, adult	10191-103E2	47.79	0.88	0.22	0.66	0.00	0.00	0.66	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	28.04	1.60	0.27	0.53	0.27	0.00	0.00	0.00